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Abstract
VAMP/synaptobrevin-associated protein of 33kDa (VAP33) was first identified in
Alplysia californica. There are two mammalian homologues ofVAP33 named VAPA
and VAPB both of which are ubiquitously expressed and have been found to associate
with the endoplasmic reticulum (ER) (Skehel et al. 2000). We have evidence that wild
type VAPA and VAPB behave differently in Triton X-l 14 and that VAPB may not be
integral to the ER. These proteins are type II membrane proteins and have a N-
terminal Major Sperm Protein (MSP) domain, a coiled-coil domain and a
transmembrane domain. Deletion of the yeast VAPA homologue, SCS2, disrupts the
regulation of the inositol biosynthesis system and the Unfolded Protein Response
(UPR) from the ER. Also in Caenorhabditis elegans the MSP is involved in
structural motility and has an Eph receptor-dependent signalling function during
oocyte maturation. This raises the interesting possibility that in addition to a
structural role, the VAP proteins may also provide a signalling function. The MSP
domain of the protein may be of particular importance for such signalling activity.
Specifically, we have found that when the VAPA MSP domain alone is expressed in
neurons it aggregates, activates components of ER stress pathways, and induces
apoptosis via caspase 3. It is possible, therefore, that VAP proteins may activate
intracellular signalling pathways through regulated interactions of their MSP domains,
and that aggregations of MSP-containing polypeptides may disrupt these systems. A
yeast two-hybrid screen was carried out using the MSP domain of VAPA and several
potentially positive interacting proteins have been identified including ATF6 and
DnaJ, which corroborate this hypothesis.
ii
These results have clinical implications as a missense mutation in the VAPB gene has
recently been identified as being associated with an atypical form of amyotrophic
lateral sclerosis (ALS8) (Nishimura et al. 2004). The P56S VAP-B mutation lies
within the highly conserved MSP domain. P56 is conserved in all VAP proteins. The
X-ray structure of the nematode MSP has been solved and the P56S substitution is
predicted to affect the multimerization state of the protein. Wild type VAP-A and B
are expressed in motor neurons but do not accumulate at the synaptic junction. We
introduced the P56S mutation into mouse VAP-B and expressed it as a GFP-fusion in
primary neurons. The substitution has a profound effect on the sub-cellular
distribution of the protein, causing accumulation of membrane associated protein
aggregates. Such a dramatic change in the sub-cellular distribution would most likely
disrupt the normal function of the protein. The P56S substitution is unlikely therefore
to represent a normal functioning polymorphism further supporting the proposal that
the mutation in the VAP-B gene is the cause of disease in the ALS affected Brazilian
family.
Acknowledgements
Firstly, I would like to thank my supervisor Paul Skehel for all his instruction, support,
patience and wisdom over the last three years. I would also like to thank Jeanette,
Aidrien and Lorna for their help and support at various times during this project. The
members of the diminishing fourth floor also deserve thanks for their encouragement and
support.
Finally I would like to thank my mum and my friends for keeping me sane through this
whole thing.
Index of Figures
Chapter 1
1.1 The endoplasmic reticulum 5
1.2 Diagram showing the major lipid content of the plasma membrane and the
ER membrane 7
1.3 Forward and retrograde transport between the transitional ER and Golgi
network is mediated by COPII and COPI vesicles 15
1.4 The ER and mitochondria in apoptosis 19
1.5 General layout of a motor neuron 26
1.6 Areas involved in motor activity in the brain and spinal cord 28
1.7 Cartoon of VAPA/VAPB and VAPC showing their major domains 32
1.8 Steps in vesicle docking and fusion applied to the glucose transporter 4
(GLUT-4) system 39
Chapter 3
3.1 Major Sperm Protein (MSP) homology domain of MSP-containing proteins
in the mouse 70
3.2 Yeast two-hybrid protein interaction screen 74
Chapter 4
4.1 The Unfolded Protein Response (UPR) and phospholipid biosynthesis are
linked in yeast 87
4.2 The mammalian ER stress response has three main effector pathways 88
4.3 Increased TUNEL staining in primary hippocampal neurons expressing
MSP-GFP 92
4.4 Increased TUNEL staining in E1EK293 cells expressing MSP-GFP 94
4.5 No gross ER disruption in cells expressing MSP-GFP 95
4.6 HEK293 tetracycline inducible cell line expressing MSP-GFP gives large
protein aggregates 97
4.7 HEK293 tetracycline inducible cell line expressing GFP 98
4.8 HEK293 tetracycline inducible cell line expressing MSP-GFP shows no cell
growth 100
4.9 HEK293 tetracycline inducible cell line expressing GFP shows normal cell
growth 101
4.10 HEK293 tetracycline inducible cell line expressing MSP-GFP undergoes
cell death 104
4.11 HEK293 tetracycline inducible cell line expressing MSP-GFP undergoes
DNA laddering, indicative of apoptosis 106
4.12 HEK293 tetracycline inducible cell line expressing MSP-GFP has increased
BiP mRNA production 107
4.13 HEK293 tetracycline inducible cell line expressing MSP-GFP has increased
phospho-PERK and caspase 3 production 110
4.14 Confirmation that HEK293 tetracycline inducible cell line expressing
MSP-GFP has increased phospho-PERK production 111
Chapter 5
5.1 VAP family homology 116
5.2 VAPA and VAPB colocalise predominantly with ER markers in primary
hippocampal neurons and E1EK293 cells 117
5.3 Colocalisation ofVAPA and VAPB 118
5.4 Fractionation and Triton XI14 extraction of endogenous VAPA and VAPB
in HEK293 cells 120
5.5 Truncation constructs ofVAPA and VAPB 121
5.6 Triton XI14 extraction ofHEK293 cells, expressing VAPA MSP-GFP 123
5.7 Triton XI14 extraction of HEK293 cells, expressing VAPB MSP-GFP 124
5.8 Triton XI14 extraction of HEK293 cells, expressing VAPA coiled-coil-GFP 125
vi
5.9 Triton XI14 extraction of HEK293 cells, expressing VAPB coiled-coil-GFP 126
5.10 Triton XI14 extraction of HEK293 cells, expressing VAPA Tail-GFP 127
5.11 Triton XI14 extraction ofHEK293 cells, expressing VAPB Tail-GFP 128
5.12 VAPA and VAPB tail comparison 130
5.13 Triton XI14 extraction of HEK293 cells, expressing VAPA-GFP without
Tail 131
5.14 Triton XI14 extraction ofHEK293 cells, expressing VAPB-GFP without
Tail 133
5.15 Triton XI14 extraction of HEK293 cells, expressing VAPA coiled-coil with
Tail-GFP 134
5.16 Triton XI14 extraction ofHEK293 cells, expressing VAPB coiled-coil with
Tail-GFP 135
5.17 Triton XI14 extraction of HEK293 cells, expressing VAPA with B
Tail-GFP 136
5.18 PCR band of correct size for VAPC in the mouse 138
Chapter 6
6.1 The P56S mutation is predicted to affect the tertiary structure of the MSP
domain 146
6.2 VAPB and VAPB P56S have different subcellular distributions 147
6.3 VAPA and VAPB without the MSP domain fused to GFP form cisternae in
the ER membrane but VAPB without the MSP domain fused to HA does not 148
6.4 VAPB and VAPBP56S and the ER 152
6.5 VAPB and VAPBP56S and cyan Golgi in HEK293 cells 153
6.6 VAPA and VAPAP56S and ER or Golgi markers in HEK293 cells 155
6.7 The VAPA MSP domain and VAPAP56S MSP domain 156
6.8 Triton XI14 extraction ofHEK293 cells, expressing VAPB-GFP 158
vii
6.9 Triton XI14 extraction of HEK293 cells, expressing VAPBP56S-GFP 159
6.10 VAPA, VAPAP56S, VAPA without Tail and VAPAP56S without Tail 160
6.11 VAPB, VAPBP56S, VAPB without Tail and VAPBP56S without Tail 161
6.12 Triton XI14 extraction of HEK293 cells, expressing VAPBP56S
without Tail-GFP 163
6.13 Cross-linking ofVAPB-GFP and VAPBP56S-GFP 164
6.14 VAPBP56S aggregates do not appear to contain wild-type VAPA or VAPB 166
Index of Tables
Chapter 1
1.1 VAP interacting proteins 36
Chapter 3
3.1 Proteins containing a two phenylalanines in an acidic tract (FFAT) motif
in mammals 72
3.2 Growth analysis of positive clones 75
3.3 Sequencing analysis of the potential positive yeast colonies identified in the
yeast two-hybrid screen 77
Chapter 5
5.1 Differences in localisation ofVAP truncation constructs 139
ix
List of abbreviations
A(3 Amyloid (3
ALS Amyotrophic lateral sclerosis
Apaf-1 Apoptosis Protease Activating Factor 1
Apo E Apolipoprotein E
APP (3 Amyloid prcursor protein
AR-JP Autosomal recessive juvenile parkinsonism
ATF6 Activating transcription factor 6
BAK Bcl-2 homologous antagonist/killer
BAP-31 B-cell leukaemia 2 associated protein of 31 kDa
Bcl-2 B-cell leukaemia 2
Bet-1 Blocked early in transport 1
BFP Blue Fluorescent Protein
Bid BH3 interacting domain death agonist
Bim Bcl2 interacting mediator of cell death
BoNT Botulinium Neurotoxin
Ca2+ Calcium ion
Caspase Cysteine dependent aspartate specific proteases
CHOP C/EBP-homologous protein
COPI Coatamer complex protein I
DTT Dithiothreitol
DAG Diacyl glycerol
DIABLO Direct IAP binding protein with low pi
eIF2a eukaryotic Initiation Factor a
EM Electron microscopy
EOR ER overload response
ER Endoplasmic reticulum
ERAD Endoplasmic reticulum associated degradation
Erp57 Endoplasmic reticulum protein 57
GFP Green Fluorescent Protein
GLUT-4 Glucose transporter 4
GRP78/BiP Glucose regulated protein of 78 kDa
GRP94 Glucose regulated protein of 94 kDa
GTP Guanine triphosphate
HAC homocysteine and cysteine
HCV Hepatitis C Virus
HEK Human embryonic kidney
INO Inositol
IP3 Inositol phosphate
IRE1 Inositol-requiring 1
JNK c-Jun N terminal kinase
KDEL Lys-Asp-Glu-Leu
LRP Low-density lipoprotein receptor-related protein
MAM Mitochondria associated endoplasmic reticulum membrane
mCu
MFP1
MFP2
mNCE
MOSPD
MPOP
MPP+
mPTP
MSP
NEM
NSF
60HDA
OMM
OPI
OSBP
PA
PACS2
PaPD
PC
PDI
PE
PERK
PS
PS1
RER
Sari
SCS2
Sec
SER
SERCA
SM
SMAC
SNAP
SNARE
SP
TeNT
tER
t-PA
TRAF
Trex
UCHLI
UPR
VAMP
VAP
VCIP135
mitochondrial Calcium ion uniporter
Membrane Fibre Protein 1
Membrane Fibre Protein 2
mitochondrial Sodium ion/calcium ion exchanger
Motile sperm domain containing protein
Membrane Phosphoprotein
1 -Methyl-4-phenylpyridinium
mitochondrial Permeability transition pore
Major Sperm Protein
N-ethylmaleimide
N-ethylmaleimide sensitive fusion protein
6-hydroxy-dopamine
Outer mitochondrial membrane
Overproduction of inositol
Oxysterol binding protein
Phosphatidic acid
Phosphofurin acidic cluster sorting protein 2
periplasmic chaperone
Phospatidyl Choline
Protein disulphide isomerase
Phosphatidyl ethanolamine
Protein kinase receptor-like endoplasmic reticulum kinase
Phosphatidyl Serine
Presenilin 1
Rough Endoplasmic reticulum
Secretion associated Ras
suppressor of choline sensitivity 2
Secretory pathway protein
Smooth Endoplasmic reticulum
Smooth Endoplasmic Reticulum calcium ion exchanger
Sphingomyelin
Second mitochondria-derived activator of caspase
Synaptosomal associated protein
Soluble N-ethylmaleimide sensitive protein attachment protein
receptor
Site protease
Tetajjflsj^oxin ~T
Transitional Endoplasmic reticulum
Tissue plasminogen activator
Tumor necrosis factor receptor associated factor
Tetracycline Repressor
Ubiquitin C-terminal hydrolase LI
Unfolded protein response
Vesicle associated membrane protein
Vesicle associated membrane protein associated protein
Valosin-containing protein (p97)/p47 complex-interacting protein
pi 35
xi
XBP1 X-box binding protein 1
TABLE OF CONTENTS
Declaration i
Abstract ii
Acknowledgements iv
Index of Figures v
Index of Tables ix
List of Abbreviations x
1. Introduction
1.1 The endoplasmic reticulum 5
1.1.1 Lipid composition of the ER membrane 1
1.1.2 Protein composition of the ER membrane 9
1.1.3 The ER as a calcium store 9
1.2 ER biogenesis 10
1.3 The ER membrane forms contact sites with other organelles 10
1.3.1 The ER membrane and the plasma membrane 11
1.3.2 The ER membrane and the mitochondrial membrane 11
1.3.3 The ER and peroxisomes 12
1.3.4 The ER and the Golgi apparatus 13
1.4 Major transport routes in mammalian cells 14
1.5 The ER and apoptosis 17
1.5.1 Bcl-2 proteins as regulators ofapoptosis on the ER 17
1.5.2 Caspases as regulators ofapoptosis at the mitochondria 21
1.5.3 Specific ER pathways associated with aopotosis 22
1.6 The ER and neurodegeneration 22
1.6.1 Alzheimer's disease and neurodegeneration 23
1.6.2 Parkinson's disease and neurodegeneration 24
1.6.3 Huntington disease and neurodegeneration 24
1.6.4 Early onset dystonia and ER membrane inclusions 25
1.6.5 Amyotrophic lateral sclerosis and neurodegeneration 25
1.7 The VAMP-Associated Protein (VAP) family and the ER 32
1.8 VAPA and insulin signalling 38
1.9 VAPA and Hepatitis C Virus (HCV) 41
1.10 Thesis Aims 43
2. Methods
2.1 Yeast 2 hybrid protein interaction screen 44
2.2 Cell line characterisation experiments 47
2.2.1 Calcium phosphate transfection ofHEK293 cells 47
2.2.2 Dissection and preparation of rat E19 primary hippocampal cultures 47
2.2.3 Nucleofection ofHEK293 cells and primary hippocampal cultures 49
2.2.4 Cell imaging and immunofluoresence 50
1
2.2.5 TUNEL staining 51
2.2.6 Creation ofan inducible stable cell line 52
2.2.7 DNA laddering 53
2.2.8 Propidium iodide cell viability assay 54
2.2.9 Northern blotting 54
2.2.10 BioRad protein assay 56
2.2.11 Western blotting 56
2.3 DNA preparation, PCR and Cloning of VAP cDNA 58
2.3.1 Amplification ofmouse cDNA library 58
2.3.2 Spectrophotometric quantitation ofnucleic acids 59
2.3.3 The polymerase chain reaction (PCR) 59
2.3.4 Primer list (Invitrogen custom primers) 60
2.3.5 Digestion ofDNA with restriction endonucleases 61
2.3.6 Gel electrophoresis ofDNA 61
2.3.7 Gel extraction ofDNA (Qiagen) 62
2.3.8 Introduction ofDNA into chemically competent bacteria 63
2.3.9 Miniprep ofbacterial plasmid DNA (Qiagen) 63
2.3.10 DNA sequencing 64
2.4 Protein localisation and multimerisation experiments 64
2.4.1 Chemical cross-linking ofprotein 64
2.4.2 Triton XI14 extraction (adaptedfrom Bordier, 1981) 65
3. Yeast-two Hybrid Screen to identify MSP domain interacting
proteins
3.1 Background 67
3.2 Yeast two-hybrid protein interaction screen using pGilda-MSP 73
3.3 Discussion 82
4. The MSP domain and the ER stress response
4.1 Background 86
4.2 Overexpression of the VAP MSP domain fused to GFP causes protein
aggregation and neuronal cell death 91
4.3 HEK293 cells expressing MSP-GFP also have large protein aggregates
and increased TUNEL staining 93
4.4 Overexpression of the MSP domain fused to GFP does not change gross
ER structure 93
4.5 Production of tetracycline inducible MSP-GFP and GFP stable cell lines 96
4.6 MSP-GFP cells show no growth after induction of protein expression 99
4.7 Induced MSP-GFP cells have increased propidium iodide staining
compared to control cells 102
4.8 DNA laddering in induced MSP-GFP HEK cells indicates apoptotic cell
death 105
4.9 HEK cells transiently transfected with MSP-GFP and VAPA have
2
upregulated levels of BiP mRNA 105
4.10 Phospho-PERK and caspase 3 levels are increased in induced
MSP-GFP cells 108
4.11 Discussion 112
5. VAPA and VAPB
5.1 Background 114
5.2 Cloning and gross cellular localisation of VAPB 115
5.3 VAPA and VAPB antibody staining overlaps but does not completely
colocalise 115
5.4 Fractionation and Triton X114 extraction of VAPA and VAPB
demonstrates a difference in localisation on the ER and differences in
membrane association 119
5.5 VAPA and VAPB MSP constructs Triton X114 extract differently 119
5.6 VAPA and VAPB coiled-coil domains are cytoplasmic 122
5.7 Triton X114 extraction reveals that the tail region of both VAPA and
VAPB are sufficient to target the protein to the correct ER subdomain 122
5.8 VAPA and VAPB expressed without the tail domain have different
cellular localisations 129
5.9 VAPA and VAPB expressed without the MSP domains co-localise with
DS.Red-ER and are in similar fractions 133
5.10 VAPA with the tail replaced with the VAPB tail localises to the same
ER subdomain as endogenous VAPB 133
5.11 Variant of VAPB found in humans, VAPC may also be present in
mice 137
5.13 Discussion 140
6. The VAP family and motor neuron degeneration
6.1 Background
6.2 VAPB and VAPBP56S have different subcellular distributions
6.3 VAPA and VAPB without the MSP domain fused to GFP form
cisternae in the ER membrane but VAPB without the MSP domain fused
to HA does not
6.4 VAPBP56S aggregates are associated with the ER membrane but are noi
enriched in the Golgi apparatus
6.5 VAPAP56S forms similar aggregates to VAPBP56S and shares the same
intracellular distribution
6.6 MSPP56S forms similar protein aggregates to MSP
6.7 Triton XI14 extraction of VAPBP56S demonstrates differences in
subcellular distribution to VAPB
6.8 P56S constructs without tails show that aggregation is not dependent on
membrane integration
6.9 Cross-linking experiments show that VAPBP56S forms higher order
3
142
145
145
149
150
150
157
157
structures than VAPB 162
6.10 VAPBP56S aggregates do not appear to include VAPA or VAPB 162
6.11 Discussion 167
7. General discussion 169
8. References 176
4
1. Introduction
1.1 The endoplasmic reticulum
The endoplasmic reticulum (ER) is involved in protein, lipid and sterol synthesis, post-
translational modification of proteins and protein and lipid transport. It is a large
organelle occupying more than 50% of cellular membranes and greater than 10% of the
cell volume (Figure 1.1). There are three separate specialized areas in the ER. The rough
ER (RER) has ribosomes and is specialized for protein synthesis. It also couples protein
synthesis to protein translocation into the lumen through the translocon. The transitional
ER (tER) has specialized cup-shaped ER cisternae from which newly synthesized
proteins exit via COPII vesicles (Barlowe et al., 1994). Smooth ER (SER) is dedicated to
Ca2+ storage and lipid and sterol synthesis. It is enlarged in cell types where increased
Ca2+ sensitivity is needed such as skeletal muscle cells and neurons.
The peripheral ER is made up of cisternal sheets, linear tubules, polygonal reticulum and
3-way junctions (Dreier et ah, 2000). In neurons the ER protrudes into both axons and
dendrites and has been morphologically identified in synaptic terminals and in
postsynaptic densities (Broadwell et ah, 1983). The cytoskeleton, in particular
microtubules, plays a major role in the cellular organization of the ER membrane.
Microtubule dynamics have been studied using time-lapse microscopy and they employ
4
Figure 1.1 The Endoplasmic Reticulum. This figure shows the stained endoplasmic
reticulum from a 3T3 fibroblast recorded via confocal microscopy (Terasaki et al., 1986).
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three different mechanisms. New ER tubules can be pulled out of existing tubules by
motor proteins such as kinesin migrating along microtubules. Secondly, the
polymerizing tips of microtubules may pull newly forming tubules along. Finally, ER
tubules may associate with the sides of microtubules via motor proteins as they slide
along other microtubules (Waterman-Storer et al., 1998). The cytoskeleton contributes
to ER dynamics but it is not necessary for ER maintenance, as when the cytoskeleton is
disrupted by addition of nocozadole the ER remains intact (Dabora et al., 1988).
1.1.1 Lipid composition of the ER membrane
There are 3 types of eukaryotic membrane lipids. They are the glycerolipids, which are
based on glycerol and include diacyl glycerol (DAG), phosphatidic acid (PA) and
phosphatidyl choline (PC). The sphingolipids are based on a CI8 sphingoid base and
include ceramide and sphingomyelin (SM). The sterols such as cholesterol are based on
a planar four-ring structure. The lipid content of different organelles within the cell is
quite different. For instance the plasma membrane is rich in sterols, sphingolipids and
saturated glycerolipids, which promote bilayer rigidity and impermeability due to their
packing density. The plasma membrane has an asymmetric lipid distribution with the
aminophospholipids concentrated on the cytoplasmic side and the sphingolipids
concentrated on the exoplasmic side (Figure 1.2). The ER membrane, however, shows
symmetric lipid distribution and primarily contains unsaturated glycerolipids that make
the membrane flexible and facilitates incorporation of newly synthesized protein
(Zachowski et al., 1993).
6
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Figure 1.2. Diagram showing the major lipid content of the plasma membrane and the ER
membrane (Holthuis and Levine, 2005).
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1.1.2 Protein composition of the ER membrane
Most membrane proteins are shared between RER and SER. However, several proteins
involved in translocation or processing newly synthesized proteins are enriched in RER
as shown by the fractionation of liver cells (Kreibich et al., 1978). Landmark proteins
from yeast tER include the COPII subunits Sec 12, Sec23, Sari and Seel 6 (Sonderholm et
al., 2004). Epoxide hydrolase is a classical marker of SER (Galteau et al., 1985).
1.1.3 The ER as a calcium store
The ER is, as a rapidly exchanging Ca2+ store, able to release Ca2+ ions upon stimulation.
A high concentration of free Ca2+ (0.2-2mM) is maintained in the lumen. This high free
2~b • • • •Ca concentration is a key factor in maintaining protein synthesis and processing.
Important Ca2+ binding proteins in the ER lumen are calreticulin, and the glucose
regulated proteins GRP78 and GRP94. Besides being a Ca2+ signaling organelle, the ER
is involved in post-translational modification of proteins. Folding of proteins is
controlled by several enzymatic systems, including peptidyl prolyl isomerases and
gylcosylation enzymes (glycosidases and mannosidases) (Chevet et al., 2001). These
systems are controlled by several families of chaperones such as, glucose-regulated
proteins (GRP78, GRP94), lectin-like chaperones (Calreticulin, calnexin and calmegin)
and protein disulphide isomerases (PDI, Erp57).
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1.2 ER biogenesis
Newly formed ER is derived from the outer nuclear membrane. In UT-1 cells where both
the level of HMG CoA reductase and the amount of crystalloid ER are regulated by
cholesterol, the membrane of the smooth ER cisternae has been identified as the
precursor of the crystalloid ER tubule. The cytoskeleton is not necessary for formation of
this tubular network in vitro and thus is presumed not to have a role in ER biogenesis.
ER network formation in extracts requires ATP and GTP and is N-ethylmaleimide
(NEM) sensitive (Dabora et ah, 1988). Inhibition of network formation by GTPyS and
NEM suggests that a Rab protein and/or a protein similar to the NEM sensitive fusion
protein (NSF) may be involved. ER network reformation requires the NEM-sensitive
AAA ATPase, p97 and the adaptor protein p47. NSFa and ySNAPs mediate the first
fusion event and the second process involves the p97/p47/VCIP135 complex and induces
fusion of the connected ER tubules to form three-way junctions (Kano et ah, 2005). A
role for p97/p47 in the in vitro formation of the tER has also been suggested (Roy et ah,
2000). tER sites are relatively stable structures and are not generated in response to
protein synthesis and transport even though they undergo fission and fusion in
mammalian cells (Watson et ah, 2005).
1.3 The ER membrane forms contact sites with other organelles
The ER forms close contacts, named ER contact sites, with other organelles including the
trans Golgi network (Ladinsky et ah, 1999), endosomes (Haj et ah, 2002), peroxisomes
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(Geuze et al., 2003), the plasma membrane (Li et al., 2004) and mitochondria (Wang et
ah, 2000).
1.3.1 The ER membrane and the plasma membrane
Contact sites between the ER and plasma membranes are found in all cell types. This
may be so that lipids can traffic bidirectionally between the ER and plasma membrane
independently of the secretory pathway. Three bridging complexes have been identified
as being important in the formation of these contact sites. In both mammals and yeast the
translocon of the RER interacts directly with the plasma membrane exocyst, which is a
large complex of proteins required for polarized exocytosis in eukaryotic cells (Guo et
ah, 2004). VAMP associated protein A (VAPA) can form bridging complexes with
peripheral membrane proteins on the plasma membrane as well as at other sites (Loewen
et ah, 2003). In phagocytes, which engulf large bodies, the plasma membrane must grow
rapidly. Under these extreme circumstances extra membrane is provided by the ER
mediated by an ER vesicular Soluble N-ethylmaleimide sensitive protein Attachment
protein REceptor (vSNARE) homologous to Sec 22 (Becker et ah, 2005).
1.3.2 The ER membrane and the mitochondrial membrane
The ER and mitochondria are also closely associated with each other. They are
physically linked in many cell types and they co-regulate some important functions
including apoptosis, lipid trafficking and regulation of Ca2+ (Levine et ah, 2004). The ER
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compartment that interacts with the mitochondria is called the mitochondria associated
ER membrane (MAM). The MAM is enriched in lipid synthases and has less ribosomes
compared with RER (Vance et al., 1990). The enrichment of lipid synthases is
compatible with one of the clearest functions of the MAM, which is to participate in lipid
traffic to and from the mitochondria (Flippin et ah, 2003). For example some of the
phosphatidyl serine (PS) synthesized in the ER is transferred to the mitochondria where it
is decarboxylated to phosphatidyl ethanolamine (PE) and then transported back to the ER
(Voelker et ah, 2000). There is emerging evidence that the ER and mitochondria can
have shared membrane proteins (Miyazaki et ah, 2005, van Herpen et ah, 2005). For
instance PACS-2 binds to the proapoptotic protein Bid in both ER and mitochondria
(Simmen et ah, 2005).
1.3.3 The ER and peroxisomes
The ER is involved in peroxisome biogenesis but peroxisomal proteins are made on
cytoplasmic ribosomes and post translationally inserted (Tabak, 2003). Peroxisomes are
ubiquitous single membrane bound organelles involved in many metabolic pathways,
which produce hydrogen peroxide. The subsequent decomposition of this toxic
compound by catalase is a fundamental peroxisome process (Kovacs et ah, 2002).
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1.3.4 The ER and the Golgi apparatus
The Golgi apparatus is a series of flattened cisternal membrane structures, which do not
fuse in a continuous manner but are closely juxtaposed in a stack-like fashion. The Golgi
is a polarized structure with a cis face, which exchanges proteins and lipids with the ER,
and a trans face, which communicates with the plasma membrane and compartments of
the endocytic pathway (Schweizer et al., 1988). EM tomography shows that the contact
between an ER domain and a Golgi stack is as close as that between the stacks of Golgi
itself (Ladinsky et al., 1999). As secretory material passes through the Golgi from the
ER in a cis to trans manner it is post-translationally modified in a sequential manner
(Griffiths et al., 1986). Post-translational modifications such as glycosylation, sulphation
and phosphorylation of proteins, proteoglycans and sphingolipids occur in the Golgi
lumen (Neutra et al., 1966, Palade et al., 1975). The trans-Golgi is particularly involved
in a number of post-translational modifications, for example sialylation, tyrosine
sulphation and proteolytic processing. This requires substrates, such as nucleotide
sugars, nucleotide sulphates and ATP to be transported into the lumen of the Golgi from
the cytosol. Transport of these substrates into the Golgi lumen occurs via antiport with
the corresponding nucleoside monophosphate (Hirschberg et al., 1987).
Glucosyltransferases and other enzymes involved in post-translational modifications
represent a significant proportion of the resident membrane protein in the trans-Golgi.
Other groups of Golgi resident proteins include retrieval receptors, matrix and
cytoskeletal binding proteins and components of the vesicular transport machinery.
12
1.4 Major membrane transport routes in mammalian cells
There are two major routes of transport in mammalian cells. The first is named the
biosynthetic route where proteins synthesized in the RER are transported to the cis-Golgi
via the intermediate compartment. The proteins then undergo post-translational
modifications and are transported to the median and trans-Golgi network. They are then
transported to the plasma membrane in vesicles and either, interact with receptors there or
are secreted via exocytotic mechanisms into the extra cellular medium (Pfeffer et al.,
2003). The second route is the endocytic pathway, which starts with the invagination of
the plasma membrane. A bud is then formed and is scissioned from the plasma
membrane. This endocytic vesicle is internalized and carries proteins, lipids, nutrients
and ligands bound to their receptors into the cell. The cargo is either transported to the
lysosyme to be degraded or to the late endosomes where ligands and their receptors are
dissociated and the receptors are recycled to the plasma membrane (Gruenberg et al.,
1995).
The coatamer proteins are involved in vesicle formation and the vesicular and target
Soluble N-ethylmaleimide sensitive protein Attachment protein REceptors (v and
tSNAREs) are involved in vesicle membrane fusion, v and tSNAREs assemble from
opposing membranes allowing the fusion of intracellular membranes along both the
biosynthetic and endocytic pathways (Sollner et al., 1993). Coatmer proteins are
responsible for vesicular transport between the ER and Golgi. COPII vesicles are
involved in the main export route from the tER to the Golgi (Barlowe et al., 1994).
Retrograde transport between the Golgi and ER involves the KDEL receptor and COPI
13
vesicles (Figure 1.3). The KDEL receptor retrieves KDEL motif luminal ER proteins
from post ER compartments (Stornaiuolo et al., 2003). The retrieval of these proteins
involves COPI vesicles (Presley et al., 2002). Movement of COPI and COPII vesicles
between the transitional ER and the Golgi is postulated to be via microtubule interactions
(Young et al., 2005).
Membrane fusion requires the assembly of the SNARE complex, which is composed of
one SNARE motif provided by the donor membrane vSNARE and three SNARE motifs
provided by two or three acceptor membrane tSNAREs. Different cell types have their
own complement of SNAREs. The neuronal synaptic vSNARE synaptobrevin 2, also
called Vesicle Associated Membrane Protein (VAMP) 2, and tSNAREs syntaxin 1 and
SyNaptosomal Associated Protein of 25 kDa (SNAP-25), are proteolysed by the light
chains of the clostridial neurotoxins [tetanus neurotoxin (TeNT) and botulinum
neurotoxin (BoNT)] that block neurotransmitter release. It was by use of these
neurotoxins (Partanello et al., 1993) and via association with NSF, aSNAP and |3SNAP
that these SNAREs were found to be involved in neurotransmitter release (Sollner, 1993).
SNAREs can also be involved in a number of other cellular processes. For instance
TeNT insensitive VAMP (TI-VAMP or VAMP-7) is involved in apical transport in
epithelial cells (LaFont et al., 1999) and in neurite outgrowth (Martinez-Areas et al.,
2000).
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Figure 1.3. Forward and retrograde transport between the transitional ER and Golgi
network is mediated by COPII and COPI vesicles (Lee et al., 2004).
1.5 The ER and apoptosis
Apoptotic cell death can be initiated by a variety of factors including perturbation of
intracellular homeostasis or the ligation of plasma membrane death receptors. Apoptosis
is a normal cellular response in development where cells, which are no longer required,
are induced to undergo cell death. It can also be activated inappropriately, and as such,
underlies the pathology of many neurodegenerative diseases. In the apoptotic death
response the cell undergoes nuclear and cytoplasmic condensation with blebbing of the
plasma membrane. The cell then breaks up into membrane-enclosed fragments, known
as apoptotic bodies, which are recognized and engulfed rapidly by neighbouring cells or
macrophages. The major proteins involved in apoptosis are the cysteine-dependent,
aspartate-specific proteases (caspases) and the B-cell leukemia 2 (Bcl-2) family
members. The caspases are the executioners of the apoptotic pathway and when they are
activated they destroy key components of the cellular infrastructure and activate cellular
factors, which damage the cell. Bcl-2 proteins act as regulators of this cell death
response. Pro-apoptotic Bcl-2 proteins can homo-oligomerise and form pores in the
mitochondrial membrane, releasing factors, which can activate the caspases. There is
increasing evidence that the ER plays an important role in the initiation of apoptosis.
1.5.1 Bcl-2 proteins as regulators of apoptosis on the ER
To be designated as a Bcl-2 family member, a protein must possess at least one of the
conserved Bcl-2 homology (BH) domains and have an effect on apoptosis. There are
three subfamilies of Bcl-2 related proteins. These are the anti-apoptotic subfamily (eg.
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Bcl-2, Bc1-Xl), the multi-domain pro-apoptotic subfamily (eg. BAK, BAX) and the pro-
apoptotic BH3-only subfamily (eg. Bim, Bad). The anti-apoptotic family has all four BH
domains and the multi-domain pro-apoptotic family has all but the BH4 domain. The
three dimensional structure of Bc1-Xl, Bid, Bax and Bclw are more similar than predicted
from their primary sequence alignments. Each protein has two central hydrophobic
helices surrounded by amphipathic helices in a structure that resembles the pore-forming
domain of the bacterial diphtheria toxin. Consistent with the known structures there is
good in vitro evidence that some of these proteins can form pores or channels in lipid
bilayers. Thus a combination of protein: protein interactions and pore/channel formation
are thought to constitute the main molecular mechanisms of Bcl-2 activity (Desagher et
al., 2000).
BH3-only proteins can either directly or indirectly activate BAX or BAK, inducing their
intramembranous homo-oligomerisation, which results in permeabilisation of the outer
mitochondrial membrane (OMM) and release of intermembrane space proteins, including
cytochrome c and SMAC/DIABLO (Wei et al., 2000, Du et al., 2000). The ER Ca2+
level is crucial in controlling the fate of the cell in response to certain stimuli, such as
ceramide, arachidonic acid and oxidative stress. Genetic or pharmacological reduction of
steady state ER Ca2+ levels is associated with resistance to apoptosis-induced by
ceramide (Zundel et al., 1998). The ER checkpoint controlled by Bcl-2 family members
resides upstream of the mitochondrion (Figure 1.4). It regulates apoptosis by modulating
mitochondrial Ca2+ uptake. Ca2+ ions may communicate death signals from the ER to the
mitochondria either directly by increasing mitochondrial Ca2+ concentration or indirectly
17
cell-intrinsic pathways through calcineurin activation. In either case Ca2+ signals
generated by inositol 3,4,5 phosphate (IP3) receptor mediated release of Ca2+ from the ER
lumen are important. The apoptotic switch in mitochondrial Ca2+ signaling can be
mediated by the pro-apoptotic protein tcBid, which increases the magnitude of
• • 9 +
mitochondrial Ca signals by selectively permeabilising the OMM (Csordas et ah, 2002).
2"b • • • •••Ca also activates cell intrinsic death pathways directly by activating calcineurin, which
dephosphorylates and activates the pro-apoptotic Bad (Wang et al., 1999) or induces Bik
(Jiang et al., 2001). The anti-apoptotic Bcl-2 associates with calcineurin in neurons and
can dock calcineurin with IP3 receptors to block IP3-mediated Ca2+ release from the ER
(Erin et al., 2003).
Members of the reticulon family are predominantly localized in the ER. These proteins
upregulate the ER localization of Bcl-2 and Bc1-Xl, resulting in inactivation of their anti-
apoptotic activity (Tagami et al., 2000). A Bcl-2 variant (Bcl-2/cb5) exclusively targeted
to the ER prevents apoptosis induced by Myc activation and by tunicamycin and
brefeldin A (Hacki et al., 2000). Bax inhibitor 1 protein, an apoptosis suppressor, also
localizes specifically to the ER (Xu et al., 1998). Bcl-2 associated protein 31 (BAP-31),
a 28kDa integral membrane protein, contains a cytosolic domain, which interacts
preferentially with pro caspase 8, Bcl-XL and Bcl-2 (Ng et al., 1997). Recently, a new
member of the BEf-only family, Spike, was isolated. It was found in the ER where it
inhibits the formation of a complex between BAP-31 and Bcl-XL (Mund et al., 2003).
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Figure 1.4. The ER and mitochondria in apoptosis (Demaurex et al., 2003). Under
7+ • • 2"h •normal conditions, Ca continuously cycles between the ER and mitochondria. Ca is
• 21
pumped into the ER by Ca ATPases (SERCA), and released by IP3-gated channels
2~F • • 2~b • •
(IP3R). Ca enters mitochondria by a Ca uniporter (mCU) and is released by a
Na+/Ca2+ exchanger (mNCE). The mitochondrial permeability transition pore (mPTP) is
important in regulating ion balance. The ER Ca2+ load reflects the balance between Bcl-2
and Bax/Bak proteins.
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1.5.2 Caspases as effectors of apoptosis at the mitochondria
Cytochrome c is a member of the mitochondrial electron transport chain that is required
for the generation of ATP. In addition to its role in cellular energetics, cytochrome c is
an important trigger of the caspase cascade. Cytochrome c mediated activation of cell
death pathways occurs if it is released from the mitochondria into the cytoplasm. In the
cytoplasm cytochrome c binds Apaf-1 to form the apoptosome. The apoptosome is a
molecular complex consisting of cytochrome c, Apaf-1, ATP and procaspase-9 and
activates caspase-9 by cleaving procaspase-9 (Lui et ah, 1996).
Caspases are the major executioners of the apoptotic pathway. They exist as latent
precursors, procaspases, which, when activated, initiate the death pathway by destroying
key components of the cellular infrastructure and activating factors that damage the cell.
Procaspases are composed of plO and p20 subunits and an N-terminal recruitment
domain. Active caspases are heterotetramers consisting of two plO and two p20 subunits
derived from two procaspase molecules. Caspases with a long N-terminal pro-domain
are initiators of apoptosis (upstream) such as caspases 2, 8, 9 and 10, or are involved in
cytokine production like caspases 1, 4, 5, 11, 12, 13. Caspases with a short prodomain
include caspase 3, 6 and 7 and are apoptotic effector proteins (downstream), and caspase
14, which is involved in cytokine maturation (Shi et ah, 2002).
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1.5.3 Specific ER pathways associated with apoptosis
The mammalian ER also has three compensatory pathways, which are activated when it
is overloaded with unfolded proteins. These pathways are the ER stress response, the ER
overload response (EOR) and the ER associated degradation pathway (ERAD). The ER
stress response leads to upregulation of chaperone proteins to assist in protein folding and
a decrease in translation of other proteins through its main effector proteins IRE1, PERK
and ATF6 (Kaufman et al., 2002). If the backlog of unfolded proteins cannot be cleared
then the ER stress response activates apoptosis via caspase-12 and CHOP-mediated
pathways (Yoneda et al., 2001). The EOR is manifested by activation of the transcription
factor NF-kB, which in turn activates various pro-inflammatory proteins and cell
adhesion molecules (Pahl et al., 1995). The ERAD pathway targets unfolded proteins in
the ER for ubiquitination and degradation by the 26S proteasome in the cytosol (Kostova
et al., 2003).
1.6 The ER and neurodegeneration
Defects in any of the ER pathways linked to apoptosis appear to be important in many
neurodegenerative diseases. In diseases where there are protein aggregates formed, such
as Alzheimer's disease, Parkinson's disease, Huntington disease, early onset dystonia and
amyotrophic lateral sclerosis (ALS), these aggregates lead to the apoptotic death of
specific subsets of neurons.
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1.6.1 Alzheimer's disease and neurodegeneration
Alzheimer's disease is a progressive degenerative disease of the brain in the elderly. The
histopathological signs of Alzheimer's disease include the presence of neuritic plaques
and neurofibrillary tangles. The neuritic plaques mostly consist of |3 amyloid (A|3)
peptide and the neurofibrillary tangles are intracellular aggregates of
hyperphosphorylated microtubular tau protein. The formation of plaques is an early
event in the pathogenesis of Alzheimer's disease that then initiates the formation of
neurofibrillary tangles (Gotz et al., 2001). The three main genes related to disease
pathogenesis are the (3 amyloid precursor protein (APP) gene, presenilin 1 (PS1) and
presenilin (PS2). When mutated these genes cause early-onset familial Alzheimer's
disease in 5% of all cases of Alzheimer's disease. There are also four other genes, which
have polymorphisms that may be risk factors for Alzheimer's disease. They are
apolipoprotein E (apo E), a-2 microglobulin, low-density lipoprotein receptor-related
protein (LRP) and very low-density lipoprotein receptor (Shastry et al., 1999). The
expression of PS1 mutants linked to familial Alzheimer's disease in human
neuroblastoma SK-N-SH cells increases susceptibility to ER stress induced by
tunicamycin or calcium ionophores and upregulates BiP mRNA. The same findings were
observed in primary neuronal cultures from PS1 mutant (I213T) knock in mice
(Katayama et al., 1999).
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1.6.2 Parkinson's disease and neurodegeneration
Parkinson's disease is characterized by muscular rigidity, postural instability and resting
tremor. It involves the degeneration of dopaminergic neurons in the substantia nigra.
The clinical hallmark of Parkinson's disease is the deposition of intracytoplasmic
inclusion bodies (Lewy bodies) in neurons. Heritable forms of the disease are caused by
mutations in three genes (Shastry et al., 1999) a synuclein, parkin and ubiquitin C-
terminal hydrolase LI (UCHL1). The Parkinson's disease mimetics 6-OHDA, MPP+ and
rotenone specifically activate ER stress pathways in cultured neuronal cells (Ryu et al.,
2002). Autosomal recessive juvenile parkinsonism (AR-JP) is caused by mutations of the
parkin gene. Parkin is an E3 ubiquitin ligase that specifically recognizes its substrate
protein, promoting its ubiquitination and subsequent degradation in the ERAD pathway
(Takihashi et al., 2003). There is also genetic evidence implicating ER stress in rare
forms of Parkinson's disease (Shimura et al., 2000).
1.6.3 Huntington disease and neurodegeneration
Huntington disease is an autosomal dominant polyglutamine disorder. The affected
individuals exhibit involuntary, jerky movements and alterations in memory and mood.
In Huntington disease there is a selective loss of striatal neurons. It is caused by
expansion of [CAG]n tracts in the huntingtin gene. This induces oxidative and ER stress,
and proteosomal and mitochondrial dysfunction (Meriin et al., 2002). Aggregation or
inclusion body formation in Huntington disease has actually been suggested to reduce
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neuronal cell death. It has been discovered that the more diffuse forms of the protein
Huntingtin are the ones more likely to cause apoptosis (Arrasate et al., 2004).
1.6.4 Early-onset torsion dystonia and ER membrane inclusions
Early-onset torsion dystonia is an autosomal dominant movement disorder beginning in
childhood and manifesting as contracted, twisted postures throughout life. Roughly 60%
of cases have an in frame GAG deletion in Torsin A resulting in the loss of a glutamic
acid residue. Torsin A is highly expressed in the dopaminergic neurons of the substantia
nigra and the dystonia is thought to arise from a disturbance in dopamine signaling
(Hewett et al., 2000). Wild-type Torsin A is expressed on the ER but the mutant protein
accumulates in multi-layered concentric membrane whorls in the cytoplasm, frequently
accompanied by flattening of the neuron cell body and loss of the neurites. The whorls
stain for Torsin A and PDI and appear to cleave from the ER. Unexpectedly, the Torsin
A protein is not a grossly misfolded protein that produces membrane inclusions by
eliciting an ER stress response. Instead, inclusion formation requires the addition of an
N-linked glycan to a specific residue in the ATP binding region of mutant Torsin A
(Bragg et al., 2004).
1.6.5 Amyotrophic lateral sclerosis and neurodegeneration
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by
progressive loss of motor neurons (Figure 1.5) in the brain and spinal cord. Amyotrophy
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is the neurogenic atrophy of muscle and lateral sclerosis refers to the hardness of the
spinal cord at autopsy, due to proliferation of astrocytes and scarring of the lateral
columns of the spinal cord. The degeneration normally begins focally and then spreads
and involves both corticospinal (Figure 1.6) (upper) and spinal (lower) motorneurons
(Brooks, 1994). Lower motor neuron degeneration results in symptoms such as muscle
denervation, loss of tendon reflexes and fasiculations, and these are followed by muscle
atrophy. Fasiculations are visible twitches of muscle that can be seen under the skin.
They result from involuntary but synchronous contractions of all of the muscles in a
motor unit. They are characteristic of slowly progressive diseases of the motor neuron
itself and are rarely seen in peripheral neuropathies. Corticospinal degeneration results
in additional focal spasticity (Swash, 1999). When corticospinal symptoms occur alone,
the syndrome is referred to as progressive bulbar palsy whereas if only lower motor
neurons are involved the syndrome is called progressive spinal muscular atrophy. The
disease progresses rapidly, in typical ALS, and leads to paralysis and death in 3-5 years.
Both environmental and genetic factors have been implicated in the pathology of ALS
and familial forms of the disease have only been found to account for roughly 10% of the
cases.
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Figure 1.5 General layout of a motor neuron (Kandel et al.. Principles of Neural Science,
4th Edition). Motor neurons are located in the ventral horn of the spinal cord and have
long axons, which synapse onto a group of muscle fibres known as a motor unit. They
have large cell bodies and their nucleus is distinctive because of its large and prominent
nucleolus. Dendritic spines are found on motor neurons, which process excitatory and
inhibitory synaptic inputs.
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Figure 1.6 Areas involved in motor activity in the brain and spinal cord (Pinel,
Biopsychology, 5th Edition). The Dorsolateral and Ventromedial tracts both initiate in
the cerebral cortex. The motor neurons activated by the Ventromedial tracts project to
proximal muscles of the trunk and limbs whereas the motor neurons activated by the
Dorsolateral tracts project to distal muscles.
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One of the most consistent cases for the involvement of environmental factors in disease
progression has been found among the Pacific Islanders of Guam. In Guam an
abnormally high percentage of the islanders have a Parkinsonian-Dementia complex plus
ALS type symptoms. This has been found to be caused by the ingestion of cycasin from
the indigenous cycad plant. Cycasin decreases neuronal DNA repair, causes an
upregulation of Tau mRNA and an increase in excitatory neurotoxicity (Esclaire et al.,
1999). Other putative environmental factors include a history of trauma to the brain and
spinal cord, strenuous physical activity, exposure to radiation, electrical shocks, welding
or soldering materials, and employment in paint, petroleum, or dairy industries. But none
of these have been reported consistently (Gubbay et al., 1985).
As previously mentioned, familial or genetic (FALS) factors account for 5-10% of ALS
cases (Kudkowicz et al., 1997). In 1993 the cytosolic copper-zinc superoxide dismutase
(SOD1) was shown to have mutations specifically linked to the development of ALS.
SOD1 is a 153 amino acid metalloenzyme with high expression in nervous tissue, liver
and erythrocytes. It catalyses the conversion of superoxide to molecular oxygen and
hydrogen peroxide (Rosen et al., 1993). Since 1993 more than 100 different mutations in
all 5 exons of the SOD1 gene have been identified as being associated with ALS
(Cudkowicz et al., 1997). Knock out models in mice, which express no SOD1, have no
ALS phenotype suggesting that it is not a loss of SOD1 enzymatic activity, which leads
to motor neuron degeneration (Reaume et al., 1996). Dominant SOD1 mutations are
thought to act as gain of function mutations (Kunst et al., 1997). Several hypotheses have
been put forward as to how the ubiquitously expressed SOD1 can mediate selective
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motor neuron death. There have been reports that SOD1 mutant mice display increased
oxidative stress (Kruman et al., 1999), that there is increased glutamate release leading to
glutamate-mediated excitotoxicity (Leigh et al., 1996, Raiteri et al., 2005), that they
display increased ER stress (Tobisawa et al., 2003, Wootz et al., 2004), that mutant
SOD1 sequesters the antiapoptotic protein Bcl-2 (Pasinelli et al., 2004) and that there is
an accumulation of ceramides and cholesterol esters in the spinal cord (Cutler et al.,
2002), all leading to motor neuron cell death.
There have been several other genes linked to various forms of ALS. Autosomal
recessive ALS (ALS2) has been linked to mutations in the Alsin gene. Symptoms in this
form of the disease begin in the 1st or 2nd decade and continue for 15-20 years. Alsin is
expressed in the brain and spinal cord and has a PH and guanine-nucleotide exchange
factor (GEF) domain. The mutations found in this gene are truncation mutations
therefore this is predicted to result in a loss of function of Alsin. It is thought that Alsin
may act as a regulator of GTPases and modulate microtubules, membrane organisation
and trafficking in neurons (Hadano et al., 2001). When the truncated form of Alsin was
expressed in monkey Cos-7 cells it resulted in enlargement and accumulation of early
endosomes, impairment of mitochondria trafficking and fragmentation of the Golgi
apparatus. It was also found to have a centrosomal localisation in SK-N-SH and SW13
cells, which suggests that it may be involved in producing microtubules (Millecamps et
al., 2005). Juvenile ALS (ALS4) is a rare autosomal dominant form of the disease
characterised by distal muscle weakness and atrophy. ALS4 has been mapped to the
STEX gene and encodes a novel 302.8kDa protein, which contains an RNA/DNA
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helicase domain. Motor neuron degeneration may be due to a dysfunction in helicase
activity or other steps in RNA processing (Chen et al., 2004).
Therefore the ER is an important organelle in the pathogenesis of many diseases.
Neurons in particular seem to be sensitive to disturbances in protein folding, especially
with the onset of old age.
1.7 The VAMP-Associated Protein (VAP) family and the ER
VAP was first identified as a VAMP/synaptobrevin-associated protein in a yeast two-
hybrid screen in Aplysia californica. Antibodies raised to the VAP protein were shown
to block neurotransmitter release in Aplysia (Skehel et al., 1995). Since then VAP
homologues have been identified in yeast (Kagiwada et al., 1998), drosophila (Pennetta
et al., 2002), mice (Skehel et al., 2000), rats (Soussan et al., 1999) and humans (Weir et
al., 1998). There are two homologues of VAP in mammalian cells, VAPA and VAPB,
and human cells also have a splice variant of VAPB called VAPC (Nishimura et al.,
1999). VAPA and VAPB have three domains a Major Sperm Protein (MSP) domain,
named for its homology to the major sperm protein of C. elegans, a coiled-coil domain,
and a transmembrane tail (Figure 1.7). VAPC contains the MSP domain and 24 amino
acids, which are not found in VAPA or VAPB.
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Figure 1.7. Cartoon ofVAPA/VAPB and VAPC showing their major domains.
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The VAP proteins are type II membrane proteins mainly expressed on the endoplasmic
reticulum (ER) (Skehel et al., 2000) and Golgi (Soussan et al., 1999) in mammalian cells
and yeast (Kagiwada et al., 1998). Mouse VAPA does not co-localise with
VAMP/synaptobrevin at synaptic structures, but expression overlaps with lower levels of
VAMP/synaptobrevin in the cell body of neurons. VAPA also associates with
microtubules and intracellular vesicles in mice. Therefore it is likely that VAPA
participates in delivery of proteins and lipids to synaptic terminals via its interaction with
VAMP/synaptobrevin rather than a direct involvement in synaptic exocytosis (Skehel et
al., 2000). Rat VAPB antibodies were found to inhibit retrograde intra Golgi transport
and to result in the accumulation of COPI vesicles (Soussan et al., 1999).
Human VAP proteins have also been shown to interact with VAMP/synaptobrevin
along with a variety of other v and tSNAREs, such as syntaxin la, betl, sec22, aSNAP
and NSF. However they do not bind to syntaxin 17, a tSNARE involved in smooth ER
traffic or to the plasma membrane tSNARE SNAP-25 (Weir et al., 2001). As VAPA is
not found in synaptic structures one hypothesis is that the VAP proteins act as a protein
chaperone for the SNARE and fusion proteins so that they cannot inappropriately interact
before they localize correctly. As sec22 is a component of the SNAREpin required for
retrograde transport to the ER (Burri et al., 2003) and betl is involved in ER to Golgi
transport (Zhang et al., 2001) it is plausible that disruption of VAP function would
indirectly disrupt transport between the Golgi and ER. The possibility does, however,
remain that the VAP proteins are directly involved in fusion events in retrograde
transport from the Golgi to the ER.
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The VAP proteins have also been identified as interacting with a number of other proteins
(Table 1.1). There is also some evidence that VAPA co-localizes with occludin at the
tight junction of epithelial cells (Lapierre et al., 1999). Drosophila VAPA is expressed at
larval neuromuscular junctions where it regulates synaptic bouton budding in a dose-
dependent manner. It is postulated to regulate division of boutons at synaptic terminals
by stabilizing and directing the microtubule cytoskeleton during budding (Pennetta et ah,
2002).
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VAP
INTERACTING
PROTEIN
VAP
INTERACTION
CELLULAR OR
BIOLOGICAL
DOMAIN CONSEQUENCE
PREDICTED
VAPA/B VAMP COILED COIL CHAPERONING
ABILITY
PREDICTED
VAPA SYNTAXIN 1A COILED COIL CHAPERONING
ABILITY
PREDICTED
VAPA Betl COILED COIL CHAPERONING
ABILITY
PREDICTED
VAPA sec22 COILED COIL CHAPERONING
ABILITY
PREDICTED
VAPA aSNAP COILED COIL CHAPERONING
ABILITY
PREDICTED
VAPA NSF COILED COIL CHAPERONING
ABILITY
VAPA OCCLUDIN UNKNOWN UNKNOWN
INDIRECT ACTION
ON GLUT4
VAPA VAMP2 COILED COIL TRANSLOCATION
TO THE PLASMA
MEMBRANE
VAPA/B NS5A OF HCV C-TERMINAL 3RD
ANCHOR OR
RECEPTOR ON ER
VAPA/B NS5B OF HCV MSP
ANCHOR OR
RECEPTOR ON ER
PREDICTED
VAPA OSBP1 MSP
EFFECT ON ER
STRUCTURE/
BIOGENESIS
VAPA ORP1 MSP UNKNOWN
VAPA ORP2 MSP UNKNOWN
PREDICTED
VAPA ORP3 MSP
EFFECT ON ER
STRUCTURE/
BIOGENESIS
VAPA ORP4 MSP UNKNOWN
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VAPA ORP6 MSP UNKNOWN
VAPA 0RP7 MSP UNKNOWN
VAPA/B 0RP9 MSP
PREDICTED
EFFECT ON ER
STRUCTURE/
BIOGENESIS
VAPB NIR1 MSP UNKNOWN
VAPB NIR2 MSP
PREDICTED
EFFECT ON ER
STRUCTURE/
BIOGENESIS
VAPB NIR3 MSP
PREDICTED
EFFECT ON
MICROTUBULE
ORGANISATION
Table 1.1 YAP interacting proteins.
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1.8 VAPA and insulin signaling
In muscle and fat cells insulin causes rapid recruitment of intracellular vesicles
containing the GLUT4 glucose transporter to the plasma membrane, thus causing an
increase in glucose entry into the cell. GLUT4 incorporation into the plasma membrane
requires the participation of VAMP-2, syntaxin-4 and synaptosome-associated protein of
23kDa (SNAP-23) in 3T3-H adipocytes (Figure 1.8). VAMP-2 is also involved in
GLUT4 arrival at the surface of L6 myoblasts expressing Myc-tagged GLUT4 (Tamori et
al., 1998). VAPA co-localises with VAMP-2 in L6 myoblasts and 3T3-L1 adipocytes
and partially co-localises with GLUT4 in L6 myoblasts. Cells expressing exogenous
VAPA showed roughly 60% less GLUT4-myc on their surface after insulin treatment
relative to insulin stimulated but untransfected or empty vector transfected controls.
However ifVAPA was coexpressed with VAMP-2-GFP then the levels ofGLUT4 on the
plasma membrane returned to control levels when stimulated. When the cells were
treated with VAPA antibody the insulin stimulated GLUT4 translocation was inhibited to
a significant extent but the basal level of GLUT4 on the plasma membrane was
unaffected. Therefore it is likely that the exogenous VAPA may limit the amount of
endogenous VAMP-2 able to mediate GLUT4-myc fusion with the plasma membrane. It
may be that the disruption of VAPA is interfering with VAMP-2 due to interrupted
protein chaperoning function or it may have a direct ability to assist in the initiating step
in GLUT4 transport. (Foster et al., 2000).
Insulin stimulated GLUT4 incorporation into the plasma membrane appears to fail in
insulin resistance accompanying several forms of diabetes (Klip et al., 1990, King et al.,
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1992). If combined with pancreatic (3 cell dysfunction this leads to persistent
hyperglycemia and its associated complications such as eye, nerve and kidney disease.
The loss of an XBP-1 allele predisposes mice to diet induced peripheral insulin resistance
and type II diabetes (Ozcan et al., 2004). As XBP-1 is a factor involved in the ER stress
response the link between ER stress and diabetes has been studied. In obese (ob/ob) and
high fat diet (HFD) mice there is increased PERK phosphorylation in liver extracts
compared with lean controls. There was also an increase in GRP78/BiP mRNA not due
to increased levels of glucose alone. ER stress inhibits insulin action in liver cells
mediated by an IRE la and JNK dependent protein kinase cascade. PERK"" mice have
been found to exhibit a phenotype resembling type I diabetes resulting from pancreatic
islet destruction soon after birth (Harding et al., 2001). PERK mutations also cause a rare
inherited form of type I diabetes in mice (Delphine et al., 2000).
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Figure 1.8 Steps in vesicle docking and fusion applied to the glucose transporter 4
(GLUT-4) system (Foster et al., 2000).
1.9 VAPA and Hepatitis C Virus (HCV)
HCV is a member of the Flaviviridae family and a positive-sense, single-stranded RNA
virus (Choo et al., 1991). The viral genome encodes a single polyprotein of about 3010
amino acids, NH2-C-El-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH, which is
proteolytically processed by viral and host proteases (Lohmann et al., 1996). There are
structural (core (C), El and E2) and nonstructural proteins (NS2-NS5B). NS3 is a serine
protease and has RNA helicase activities (Tai et al., 1996), suggesting its potential role in
viral RNA synthesis. NS5B is a RNA dependent RNA polymerase (Poch et al., 1989).
NS5A is a phosphoprotein (Tanji et al., 1995) and contains a putative nuclear localization
signal that can target a heterologous reporter gene product to the nucleus. The N-
terminus truncated, but not the full-length, NS5A is a potent transcriptional activator
(Kato et al., 1997). It has recently been shown that NS5A has potential BH1, BH2 and
BH3 sites and interacts with Bax to inhibit apoptosis (Chung et al., 2003).
VAPA has been shown to interact with NS5A and NS5B with the MSP domain binding
to NS5B and the C-terminal 3rd of VAPA interacting with NS5A (Tu et al., 1999). The
VAPA protein acts as an anchor or receptor for these HCV proteins to localize them to
the ER membrane where they can carry out HCV replication and translation. Small
interfering (si) RNA-mediated down regulation of VAPA in Huh-7 cells blocked HCV
replication and translation (Zhang et al., 2004). When NS5A is hyperphosphorylated this
interrupts its interaction with VAPA and this negatively regulates viral RNA replication
(Evans et al., 2004). There is also some evidence to suggest that VAPA can localize with
HCV to lipid rafts and that it has a role in HCV and encephalomyocarditis virus (EMCV)
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internal ribosomal entry site (IRES)-mediated translation (Gao et al., 2004). It has been
suggested that VAPA may be a cellular factor playing a role in regulating the switch
between replication and translation ofHCV RNA.
In order to ensure viral replication and survival, the HCV proteins modify the host ER
stress response. NS5A inhibits the double stranded RNA dependent eIF2a kinase PERK
and prevents its dimerisation (Gale et al., 1997). As cells expressing NS5A have lower
levels of eIF2a phosphorylation this increases translation initiation and alters ER stress
pathways (Tardif et al., 2004). Cells expressing HCV replicons can also activate the
UPR via ATF6 (Tardif et al., 2002). NS5A can activate the EOR after disturbing
intracellular Ca2+ levels leading to the activation of NFkB and STAT-3 (Gong et al.,
2001). It is possible that the effects of NS5A on ER stress pathways may be in part
mediated via its interaction with VAPA.
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1.10 Thesis aims
The aim of this thesis is to study the MSP domain of the mammalian VAP proteins in
greater detail. Especially in its potential roles in the ER stress response and in some
forms of familial Amyotrophic Lateral Sclerosis (ALS). In order to carry out this aim a
variety of techniques, such as, a yeast two hybrid screen with VAPA MSP and a VAPA
MSP domain inducible stable cell line will be used, along with characterization of the
VAPB mutant VAPBP56S.
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2. METHODS
2.1 Yeast 2 hybridprotein interaction screen
DupLEX-A™ YEAST TWO-HYBRID SYSTEM. This is a Lex-A-based version of the
yeast two-hybrid system originally developed by Fields and Song. In the Lex-A system
the DNA binding protein is the E. coli Lex-A protein and the activation protein is the acid
blob domain B42. The DNA binding protein and the activation protein cannot activate
reporter expression on their own but when they are brought together via two interacting
proteins they activate reporter gene expression.
The MSP domain of VAPA (containing the coding sequence for amino acids 1-101) was
cloned into the yeast bait vector pGilda. The bait vector pGilda-MSP, or one of the
control vectors pRHFMl or pSH17-4 was then transformed into the yeast strain EGY48
along with the reporter plasmid, pSH 18-43. This was done in order to determine whether
the bait vector autoactivated the reporter plasmid. pGilda-MSP was then transformed
into the yeast along with pJKlOl to test if it could bind to the LexA operators in the
nucleus when activated by galactose. The pGilda-MSP bait plasmid did not autoactivate
the SHI8-34 reporter plasmid therefore the yeast containing the bait and reporter
plasmids was subjected to a large-scale lithium acetate transformation with the LexA
JG4-5 library plasmid. A yeast colony containing the pGilda-MSP and pSH18-34 was
picked and grown up overnight in YNB(glu)-his-ura medium at 30°C. This overnight
culture was then diluted to OD600 0.1 in YPD medium and grown for a further 4 hr. The
cells were then harvested by spinning at 1500g for 5 min, washed in 30ml of distilled H2O
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(dH20) and spun again. The supernatant was poured off and the pellet resuspended in
1.5ml LiOAc. 30 50ql aliquots were made and 50p,g of carrier DNA and lpl of JG4-5
library plasmid were added. Then 300ql of LiOAc/PEG was added to each tube and the
tube inverted and incubated at 30°C for 30 min. 40pl DMSO was added to each tube and
then they were mixed by inversion and heat shocked at 45°C for 20 min. 0.6p,l of dH20
was added to each tube, they were mixed by inversion and plated onto 30 24x24 cm
YNB(glu)-his-ura-trp plates. 5x106 clones were calculated to have been obtained via a
100mm titration plate and these were harvested with a sterile microscope slide and frozen
in 50% glycerol aliquots. An aliquot of yeast was then grown in minimal YNB(gal)-his-
leu-trp-ura medium until there were approximately 4xl07 cells (calculated via a titration
of viable cells). These cells were then plated onto YNB(gal)-his-leu-trp-ura plates to gain
potential positive transformants and clonies were picked at 48 and 72hrs. 115 potential
positive transformants were gained and these were tested on X-gal plates. Overall 40
colonies were obtained which were blue and therefore true positives. DNA was isolated
from the positives by growing each colony in 2 ml of YNB(glu)-trp medium at 30°C
overnight. 1.5ml of each was centrifuged in eppendorf tubes for 10s at maximum speed.
The supernatant was poured off, the pellet was vortexed to resuspend it in the residual
liquid, then 200ql of plasmid rescue solution was added. lOOql of phenol (tris-sat pH
8.0) and lOOpl of 24:1 chloroforrmisoamyl alcohol (Gibco) was added along with 0.3g of
acid-washed glass beads and this was vortexed vigorously for 2 min. This mixture was
centrifuged at 14K rpm in a microcentrifuge for 5 min at room temperature. 200ptl was
removed from the top (aqueous) layer and transferred to a clean eppendorf tube. 20ml of
3M NaOAc (Sigma) was added, the solution was vortexed, and then 440ql of 95%
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ethanol was added. The solution was centrifuged for 20 min at 14K rpm in a
microcentrifuge, the supernatant pipetted off and discarded. Then it was washed with
70% ethanol and the supernatant discarded, the pellet vacuum dried and resuspended in
5 pi of sterile distilled water. 1 pi of the DNA was used to transform the E. coli KC8 cells
and they were plated onto ampicillin LB (Sigma) plates. Colonies were restreaked onto -
trp plates and those that grew were harvested by miniprep and sequenced.
All materials obtained from Q-BIOgene unless otherwise stated.
Yeast medium - YNB-ura-his-Ieu-trp (or other selective medium):
6.7 g yeast nitrogen base w/o amino acids
0.6 g -his-ura-trp-leu (or other selective) dropout mix
20 g glucose (or 20 g galactose + 10 g raffinose for gal/raff media) (Sigma)
20 g agar (if for plates) (Sigma)
Add 1 liter of distilled water and autoclave for 20 minutes.
For plates, cool to 50°C before pouring
Yeast selective X-gal media - 6.7 g yeast nitrogen base without amino acids
0.6 g -his-ura-trp-leu dropout mix
20 g glucose (or 20 g galactose + 10 g raffinose for gal media) (Sigma)
20 g agar (Sigma)
900 ml distilled water
Autoclave and cool to 65°C
In a separate bottle, autoclave 7 g of sodium phosphate (dibasic) and 3 g of
sodium phosphate (monobasic) in 100 ml of distilled water (Sigma)
Mix the two solutions, add 0.8 ml of 100 mg/ml 5 bromo-4-chloro-3-indolyl-
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beta-D-galactopyranoside (X-gal) in N,Ndimethyl formamide, and pour
plates
2.2 Cell line characterisation experiments
2.2.1 Calcium phosphate transfection of HEK293 cells
HEK293 cells were maintained in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin (Invitrogen) at 37°C in 5% CO2. For transfection with the
plasmids HEK cells were plated at 40-60% confluency. A solution of 1.25mM calcium
chloride, 1 pg of plasmid DNA, and N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid
(BES) buffered saline, pH 6.95 (Sigma) in culture medium, was then added. This gave a
calcium phosphate precipitate, which initiated DNA entry into the cells. HEK cells were
incubated for four hours at 37°C in 5% CO2. The solution was then removed and
replaced with fresh culture medium.
BES-Buffered Saline (2X) - 280 mM NaCl
Filter sterilize and store at -20°C
1.5mM Sodium Phosphate Dibasic (Na2HP04)
50mM BES, pH 6.95
2.2.2 Dissection and preparation of rat E19 primary hippocampal cultures
Flippocampi of El9 rat embryos were dissected. The hippocampi were transferred to a
35mm dish containing 2ml of Hank's/Hepes Solution and 200pl of Trypsin and 20pl of
DNAse solution were added. The dish was placed into the incubator at 37°C for 20
minutes. After 20 minutes at 37° C, 5 ml of the growth medium was added to the dish.
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This was transferred to a tube and made up to 10 ml by adding growth medium. The
hippocampi were allowed to settle down to the bottom of the tube. The solution was
removed and the cells were washed once more with 10 ml of growth medium. The
hippocampi were then centrifuged at 1200rpm for 5min and the solution was removed
and 2ml of growth medium and 20p,l of DNAse were added. The cells were triturated
with a fire polished Pasteur pipette. The cells were counted and plated down in 6 well
PLL coated plates at the appropriate concentration (usually 100.000 to 800.000 cells per
well). The day after the preparation the old media was removed and replaced with 1,5ml
of serum free medium.
All materials are obtained from Invitrogen unless otherwise stated.
HDMEM - 25mm Hepes buffered Dulbeccos mod. medium (500ml) + 5ml Pen-strep
HEBSS - Hepes buffered Calcium and Magnesium free Earls BSS pH 7.3
EBSS - (Earls BSS) + lOmM Hepes (that is 238mg Hepes for 100ml HBSS): pH 7.3
L-15 - (Leibovitz) medium with L-Glutamine W/ L-Amino Acids.
Add 5ml of Pen-strep to a 500ml bottle of L - 15.
Hanks /Hepes solution - HBSS 500ml + 1.19g Hepes (PH to 7.3 and Filtered)
Trypsin Solution - Dissolve lOOmg Trypsin in 10ml of Ca2+/Mg2+ free PBS
Filter to sterilise and stock in 200pl aliquots in the freezer
DNAse solution - 5mg DNAse (Sigma) dissolved in 1 ml of PBS
Growth Medium - 500ml BME
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50ml Horse Serum
5ml Pen-strep
8ml of a 32.5% Glucose Solution (in water, sterile)
5ml Sodium Pyruvate 100 mM solution
5ml N2 supplement
Filter through a 0.2pm sterile filter.
Serum free medium - 500ml BME
5 ml Pen-strep
8 ml of a 32.5% Glucose Solution (in water, sterile)
5 ml Sodium Pyruvate lOOmM solution
5 ml N2 supplement
10 ml B27 supplement
Filter through a 0.2pm sterile filter.
PLL solution stock solution - lOmg/ml in distilled water. Further dilution 200pl to
40ml.
Fibronectin stock solution - lmg/lOml. Further dilution 1ml to 10ml
2.2.3 Nucleofection of HEK293 cells and primary hippocampal cultures
Using the Cell line Nucleofector™ Kit (Amaxa biosystems). The supplemented
Nucleofector solution V was pre-warmed to room temperature and culture medium was
pre-warmed to 37°C. For FIEK293 cell nucleofection 6 well plates were prepared by
adding 1ml of culture medium to the required number of wells. The cells were grown to
the required confluency and harvested by trypsinisation. For primary cultured cell
49
suspension hippocampal cells were nucleofected before plating. An aliquot of detached
cell suspension was taken and the cells were counted to determine the cell density. The
required number of cells (106 cells per nucleofection sample) was centrifuged at 200xg
for 10 minutes. The supernatant was discarded and the pellet was resuspended in
Nucleofector solution V to a final concentration of 106 cells/100pi. lOOpl of cell
suspension was mixed with 5pg of DNA (in 5pl of H20). The nucleofection sample was
transferred into a cuvette, placed into the Nucleofector and electroporated, using the
appropriate program. 500ul of culture medium was added to the cuvette and the sample
was transferred to the prepared 6 well plates using the plastic pipettes provided. Cells
were then incubated in a 37°C/5% C02 incubator for 24 hours before being imaged.
2.2.4 Cell imaging and immunofluoresense
Live cells were split into 6 or 12 well plates and transfected with green fluorescent
protein (GFP) or red fluorescent (DS.Red) fusion constructs via calcium phosphate
transfection or nuclefection. After 12-48 hours these cells were imaged using an
Olympus 1X70 fluoresense microscope with a 40X objective. Cells were objectively
screened under phase to determine whether they were healthy. They were then screened
to identify those that had lower levels of overexpression and only those cells that had
approximately 30-70% overexpression as determined by fluorescence levels were
imaged.
For confocal microscopy cells were seeded at an appropriate density on coverslips coated
with poly-D-Lysine. Growth medium was aspirated, replaced with fixative and incubated
at room temperature for 15-20min. The fixative was aspirated, perm/quench added and
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then immediately aspirated and replaced with fresh permeating and quenching solution
(perm/quench). Cells were incubated in perm/quench for 10-15 minutes. The
perm/quench was aspirated and replaced with PGAS and incubated for 5 minutes. The
primary antibody was diluted in PGAS and added to the coverslip. The coverslip was
incubated in a humidified chamber for 1 hour. The coverslip was then washed in PGAS
and then the secondary antibody was added and incubated in a humidified chamber for 1
hour. The coverslip was washed in PGAS and then was washed 3 times in PBS. The
coverslip was attached to the slide with a drop of mowiol 4-88 and stored in the dark for
at least 4 hours before being imaged on the BioRad Radiance 2000 confocal microscope
with 60X oil immersion lenses.
All materials are obtained from Sigma unless otherwise stated.
Fixative - 3% paraformaldehyde (PFA) and 0.1% gluteraldehyde in phosho-buffered saline (PBS).
Perm/quench - 50mM NH4C1 and 0.2% saponin in PBS.
PGAS - 0.2% gelatin, 0.02% saponin, and 0.02% NaN3 in PBS.
2.2.5 TUNEL staining
Using the Oncogene DNA fragmentation detection kit for Terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end labelling (TUNEL) of DNA fragments. HEK
and primary hipoocampal cultured cells were fixed as above. When the coverslips were
removed from PGAS they were covered with 50-1 OOpil of Proteinase K for 5min to
remove exogenous protein from the cells. They were then washed 3 times in PBS. The
samples were covered in 50pl of 3% IT2O2 for 5min to inactivate endogenous peroxidases
and then rinsed once in PBS. The coverslips were then incubated with 100pi of the
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supplied buffer to equilibrate the samples at the correct pH for lOmin. The equilibration
buffer was gently removed and the cells were treated with 57pl TdT labelling reaction
mix and 3pl TdT enzyme and incubated for 1.5hr in a humidified chamber at 37°C. The
coverslips were removed from the chamber, excess liquid was blotted off and lOOpil of
the supplied buffer to end the reaction (Stop buffer) was applied for 5min. The Stop
buffer was removed with a PBS rinse and the coverslips were treated with lOOpl of the
supplied blocking buffer for 1 Omin. The blocking buffer was carefully removed and the
samples were treated with lOOpl of IX conjugate for 30min. The coverslips were washed
in PBS and then lOOpl of 3,3'-diaminobenzidine tetrahydrochloride (DAB) solution was
added for 15min. The cells were rinsed with dTBO and the coverslips were attached to
the slide with a drop of mowiol and stored in the dark for at least 4 hours before being
imaged with oil immersion lenses.
2.2.6 Creation of an inducible stable cell line
Using the Trex System from Invitrogen based on tetracycline inducible expression via
repression of transcription in the absence of tetracycline. The MSP domain of VAPA
fused to the carboxy terminus of GFP was ligated into pcDNA4/TO. This plasmid was
then treated with the restriction endonuclease Seal, which cleaved the plasmid and
increased the efficiency of genomic integration, and transfected into HEK cells stably
expressing pcDNA6/TR using the calcium phosphate method. Cells were left to grow for
48hrs post-transfection. The growth medium was aspirated and they were then treated
with 50p,g/ml zeocin in fresh growth medium. The selective medium containing zeocin
was replenished every 3-4 days until zeocin resistant colonies were detected. 24 zeocin-
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resistant colonies were picked and put into a 24 well plate. These colonies were grown
for a further 48 hours and then tested with lpg/ml tetracycline to check inducible gene
expression. 4 colonies were found have good inducible expression and these colonies
were grown up further and then frozen down or expanded for further experimentation.
All materials obtained from Invitrogen unless otherwise stated.
Growth medium - DMEM
10% Foetal Bovine serum
1% Penicillin/Streptomycin
2.2.7 DNA laddering
Cells were grown to confluence, trypsinised, washed and counted. 106 cells were pelleted
and the supernatant was discarded. Cells were resuspended on ice in 20pl of lysis buffer
and pipetted to ensure complete lysis. They were then incubated at 55°C for 1 hour. The
cell debris was pelleted at 14,000rpm in a tabletop microfuge and 5 pi of 20mg/ml RNase
A was added to the supernatant. This was incubated at 55°C for 1 hour. The sample was
centrifuged briefly to pellet any further cell debris and the supernatant was collected.
The supernatant was heated to 70°C for 2 minutes and mixed with lOpl of loading buffer.
This was run on a 2% agarose gel containing 0.5pg/ml ethidium bromide at 40V for 2
hours and visualised under UV light.
All materials obtained from Sigma unless otherwise stated.
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Lysis buffer - 50mM Tris-HCl (pH 8)
lOmMEDTA
0.5% SDS
0.5mg/ml proteinase K
2.2.8 Propidium iodide ceil viability assay
Cells were plated and grown to 20-40% confluency. A 50X stock solution of 250ml/ml
of propidium iodide (Sigma) solution was prepared in distilled water. The desired
amount of cell culture medium was made up with IX propidium iodide. The medium on
the cells was carefully aspirated and replaced with the medium containing propidium
iodide. The cells were incubated for 20 min at 37°C and then imaged. Viable cells were
detected on a fluorescent microscope as those, which excluded the propidium iodide.
2.2.9 Northern blotting
HEK293 cells were calcium phosphate transfected with Green Fluorescent Protein (GFP),
Blue Fluorescent Protein (BFP), MSP-GFP/TO, VAPA-GFP, and tPA-GFP. The cells
were lysed in 1ml Trizol reagent (Invitrogen) and incubated for 5min at room
temperature to permit complete dissociation of the nucleoprotein complexes. 0.2ml of
chloroform was added and the tubes were shaken by hand for 15s and then incubated at
room temperature for a further 3 minutes. The samples were spun at 12K x g for lOmin
at 4°C. The aqueous phase was moved to a clean eppendorf tube and 0.5ml isopropyl
alcohol was added. The samples were incubated for lOmin at room temperature and then
spun at 12K x g for lOmin at 4°C. The supernatant was removed and the RNA pellet was
washed with 1ml of 75% ethanol, vortexed and centrifuged at 7,500 x g for 5min at 4°C.
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The supernatant was carefully removed and the RNA was air-dried for 1 Omin. The RNA
was then resuspended in DEPEC H2O for lOmin at 60°C and the optical density of the
RNA was measured via spectrophotometeric analysis. 2[xl of each RNA sample was
suspended in a mixture of 2pil 10X MOPs, 4|al formaldehyde, 10pl formamide and lfil
ethidium bromide. The samples were incubated at 85°C for lOmin, transferred to ice for
lOmin and 2|il of formaldehyde gel loading buffer was added. The RNA was subjected
to electrophoresis on a 1.5% agarose gel containing IX MOPs at 125V. The RNA was
transferred from the gel to a nylon membrane (Hybond-N) using a turboblotter. The BiP
hybridisation probe (encoding the entire BiP cDNA) was made using the Prime-it
Random Primer labelling Kit (Stratagene) and was labelled using [a-32P] dCTP. For the
hybridisation of the BiP probe to the mRNA on the membrane the Hybridisation Buffer
with 50% formamide was preheated to 65°C and the membrane was prehybridised in this
solution for lhr. 50p,l of the BiP probe was then added to 10ml of the Hybridisation
Buffer and the membrane was incubated with this solution overnight at 65°C. The
membrane was washed twice with 2X SSC containing 1% SDS for 5min at room
temperature and then washed twice with 0.5X SSC containing 1% SDS for 5min at 65°C.
The membrane was imaged using a phospho-imager.
All materials obtained from Sigma unless otherwise stated.
Formaldehyde gel loading buffer - 62.5% Formamide
9.25% Formaldehyde
1,25x MOPS Buffer
50 pg/ml Bromophenol Blue (BPB)
50 pg/ml Xylene Cyanol (XC)
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10X MOPS - 0.4M Morpholinopropanesulfonic acid (free acid)
0.1 M Sodium acetate
lOmM EDTA
adjust to pH 7.2 with NaOH
store dark in fridge
20 x SSC - 3M NaCl
0.3M Sodium Citrate
2.2.10 BioRad protein assay
Prior to western blotting samples were subjected to a protein assay to ensure that a
standard amount of protein (10-20pg) was loaded in each well. The BioRad dye reagent
concentrate was diluted 1:4 and filtered. Five dilutions of BSA protein standard
(BioRad) were prepared in the range 0.2 to 0.9 mg/ml. Five dilutions of the protein
sample to be used in western blotting were also prepared. 100pl of each standard and
sample solution were added to a test tube. 5ml of diluted dye reagent was then added to
each test tube, the samples were vortexed and incubated at room temperature for 5
minutes. The absorbance of the samples and standards at 595nm was then measured and
the concentration of the sample solutions was determined by comparing the absorbance
levels to that of the standards.
2.2.11 Western blotting
Samples were suspended in SDS loading dye and run on a 10% or 4-20% SDS gel at
125V in Tris-Glycine running buffer. They were then transferred to a pvdf (Hybond-P)
membrane in CAPS buffer at 25V for 16 hours. The pvdf membrane was then incubated
in 5% non-fat milk for lhr at room temperature. The membrane was incubated with the
56
appropriate primary antibody (VAPA (Skehel et al., 1995), VAPB (GeneTex), GFP
(molecular probes), phosphPERK (Cell Signalling Technology), caspase 3 (Cell
Signalling Technology) or HA (Upstate)) for lhr. The membrane was washed twice in
PBS plus 0.1% Tween20 for 5 minutes and then incubated for lhr in the appropriate
secondary antibody (Goat anti-rabbit or Donkey anti-sheep). The blot was then washed
three times in PBS plus 0.1% Tween20 for 10 minutes. ECL detection buffer was added
to the blot, which was then exposed on Kodak film and analysed.
All materials obtained from Sigma unless otherwise stated.
SDS loading Dye (2X) - 80mM Tris (pH 6.9)
2% SDS (Bio-Rad)
lOOmM DTT
10% Glycerol (Bio-Rad)
0.004% bromophenol blue
10% Resolving Gel - 4ml 20% acrylamide (Bio-Rad)
2.5ml resolving buffer (pH 8.8)
3.3ml dHzO
200pl 10% APS (Bio-Rad)
5pi Temed (Bio-Rad)
Stacking Gel - 0.5ml 20% acrylamide (Bio-Rad)
1,3ml stacking buffer (pH 6.8)
3.2ml dH20
40pl 10% APS (Bio-Rad)
5pl Temed (Bio-Rad)
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Tris-Glycine Running buffer (10X) - 30g Trizma
140g Glycine
50ml 20% SDS (Bio-Rad)
dH20 to 1 litre
CAPS transfer Buffer (50X) - 0.5M CAPS (pH 11.5)
2.3 DNA preparation, PCR and Cloning ofVAP cDNA
2.3.1 Amplification ofmouse cDNA library
Using the GENETRAPPER® protocol (adapted from Hanahan et al., 1991) for semi¬
solid amplification of plasmid cDNA libraries. 2 litres of 2X LB were prepared. 200mls
were removed and used to make the 2X LB glycerol. 5.4g of SeaPrep agarose were
added to the 1.8 litres of 2X LB and this was autoclaved. The LB agarose was then
cooled to 37°C and 200pg/ml of ampicillin (Invitrogen) was added. 4 x 105 - 6 x 105
colonies from the original mouse brain cDNA library were added and then incubated for
1 hour in an ice bath. The colonies were then incubated in a gravity flow incubator at
30°C for 40-45 hours without disturbance. The colonies were removed from the
incubator and spun at 8000 rpm for 20 minutes at room temperature. The supernatant
was poured off and the colonies resuspended in 100 ml of 2X LB glycerol (12.5%). The
colonies were split into aliquots and stored at -70°C.
All materials are obtained from Sigma unless otherwise stated.
2 X LB - 20 g Tryptone (Fisher)
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10 g Yeast Extract
lOgNaCl
Bring to 1,000 ml H20.
2 X LB Glycerol (12.5%) - 175 ml 2 X LB
25 ml Glycerol (100%)
Filter sterilise and store for up to two months at room
temperature.
2.3.2 Spectrophotometric quantitation of nucleic acids
Nucleic acid concentrations were determined by measuring the UV absorbance at 260nm
of diluted samples (Beckman DU-7 spectrophotometer). Assuming the molecular weight
of a nucleotide pair is 660 Daltons, an OD260 absorbance of 1 is equivalent to 50pg/ml
for double stranded DNA, 40pg/ml for RNA and 33pg/ml for 20mer oligonucleotides
(Sambrook et al., 1989).
2.3.3 The polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) allows amplification of a specific DNA fragment in
vitro. Extension of the annealed primers with a DNA polymerase from the thermophilic
bacterium Thermus aquaticus (Taq) or Pyrococcus furiosus (Pfu) polymerase, for
increased fidelity, in the presence of deoxynucleotides result in amplification of the target
DNA. The standard PCR conditions described by Ashworth (1993) were used. Each
50pl reaction contained the following components:
5(0.1 of lOx PCR buffer (150mM Tris-HCl pH 8.8, 600mM KC1, 22.5mM,
MgCl2),
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1.25(J.1 of lOmM dNTPs ,
1 (j.1 (lOpmol) of each of two primers,
lUnit of Taq or pfu DNA polymerase
water and 50ng template DNA to a total volume of 50pl.
A single working stock of PCR components, minus template DNA, was made to reduce
reaction variation. The template, added last to reduce chances of cross-contamination,
was plasmid DNA (~l-10ng), genomic DNA (~50ng) or cDNA libraries (~l-5pl). All
sets of reactions included a sample, lacking template DNA as a negative control. The
PCRs were carried out on a programmable thermocycler (Robocycler or ABI9700).
Generally, the samples underwent 30 cycles of:
(a) denaturation at 94°C for 0.5 min.
(b) annealing at 50-55°C for 0.5 min.
(c) extension at 72°C for 1 min.
followed by 5 min. at 72°C.
In most cases the products of the PCR reaction were treated with restriction enzymes and
ligated into the plasmid vectors EGFP-C1, pcDNA4/TO or monomeric DS.Red-Cl.
These vector constructs were then introduced into chemically competent TOPI OF
bacteria.
2.3.4 Primer list (Invitrogen custom primers)
Name Sequence Construct/vector
5' 3'
VAPB1 GCGAATTCCATGGCGAAGGTGGAACAG Full-length VAPB
VAPB2 GGGTGATCAGCGGCCGCCCCTACAAGGCAATCTTCCCT Full-length VAPB
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Pointmutl TCCCACTGTTGGACCGCACACAGTA
Pointmut2 TACTGTGTGCGGTCCAACAGTGGGA
Pointmut3 TACTGCGTGCGGTCCAACAGTGGGG
Pointmut4 CCCCACTGTTGGACCGCACGCAGTA
VAPB5 GACGGATCCCTACATCGCCTTCCTCAC
VAPB6 GCGAATTCCGCAAAACCGGAAGACCTT
VAPC1 GACGGATCCGCTAAGGCCCTCCTCCTT
VAPB7 GACGGATTCCTATTTTGCCTCCTTCCA
Yeastl CTGAGTGGAGATGCCTCC
Yeast2 GCCGACAACCTTGATTG
417 CGTCAGCAGAGCTTCACCATTG
483 AAAGGATCCGCTCTGGCGGCCACTGGGAAG
VAPAP56S
VAPAP56S
VAPBP56S
VAPBP56S
VAPB/VAPBP56S
without tail
VAPB coiled-coil
with tail
VAPC
VAPB MSP
pJG4-5
pJG4-5
pGilda
VAPB tail with
Bam HI site
2.3.5 Digestion of DNA with restriction endonucleases
DNA was digested with restriction enzymes using the manufacturer's recommended lOx
restriction buffers and digestion temperatures (New England Biolabs). Routinely, 1 pg of
plasmid DNA was digested for 1 hour at 37°C in a total volume of lOpl of lx restriction
buffer using between 5-10 units of restriction endonuclease, such that the volume of
restriction enzyme did not exceed one tenth of the reaction volume.
2.3.6 Gel electrophoresis of DNA
Agarose gel electrophoresis was used to size or separate DNA fragments within the range
50bp-20kb. Electrophoresis was carried out using a horizontal gel electrophoresis
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apparatus according to the manufacturer's operating instructions. Gels were made from
0.8-2.0% agarose melted in lx TAE buffer (40mM Tris-HCl, pH7.8; 20mM sodium
acetate; ImM EDTA, pH8.0) containing 0.5pg/ml ethidium bromide solution. The
melted agarose was cast in a horizontal gel tray after cooling to 60°C with a suitably
positioned comb to form slots in the gel. The gel, once solidified, was submerged in lx
TAE buffer with 0.5pg/ml ethidium bromide. DNA solutions (O.lpg-lOpg) were
resuspended in loading buffer (0.25% w/v bromophenol blue; lOOmM EDTA; 30%
glycerol) and loaded into the wells of the gel. The samples were electrophoresed at 65V
in parallel with double-stranded DNA size markers DNA was visualised using short- or
long-wave ultraviolet light.
2.3.7 Gel extraction of DNA (Qiagen)
The DNA band was visualised under long wavelength (365nm) ultra-violet light and
excised from the agarose gel using a clean, sharp scalpel. The agarose containing the
DNA band was placed in an eppendorf tube 3 volumes of buffer QXI plus 2 volumes of
dH20 were added to the tube. The Qiaex II was vortexed for 30s and then 1 Opil were
added. This was then incubated at 50°C for lOmin and vortexed every 2min. The
solution was then centrifuged at full speed in a tabletop microfuge for 30s and the
supernatant discarded. The pellet was resuspended in 500pd of buffer QXI and then
centrifuged for 30s and washed twice in 500pl of solution PE (70% ethanol). The pellet
was air dried for 10-15min and then resuspended in 20ml of dEfiO and incubated at 50°C
for 5min. The suspension was then centrifuged for 30s and the supernatant containing
the DNA was pipetted into a clean tube.
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2.3.8 Introduction of DNA into chemically competent bacteria
One 50 pi vial of One Shot® cells (Invitrogen) for each transformation was thawed on
ice. lpl of DNA or ligation mix was added to the cells and the vial was incubated on ice
for 30min. The vial was then incubated at 42°C in a pre-heated water bath for 30s and
placed back on ice. 250pl of SOC medium was added to the vial and it was incubated at
37°C for one hour in a rotary shaker-incubator. 10-50pil of each vial was spread onto
plates containing either the appropriate antibody selection.
2.3.9 Miniprep of bacterial plasmid DNA (Qiagen)
An overnight culture of a single bacterial colony was grown in 2ml Luria-Bertani (LB)
medium at 37°C in a rotary shaker-incubator. 1.5ml of the bacterial culture was pipetted
into an eppendorf tube and centrifuged at 14K rpm in a tabletop microfuge. The
supernatant was pipetted off and discarded and the pellet was resuspended in 250pl of
buffer PI containing RNase A to remove RNA contamination. The bacterial cells were
then lysed in 250pil NaOH/SDS (buffer P2) for 5min. The lysate was neutralized by the
addition of 350pil of buffer N3 and the high salt concentration of this buffer allowed the
chromosomal DNA and denatured proteins to precipitate leaving the plasmid DNA. The
suspension was then centrifuged at 14K rpm for 10 min. The supernatant was added to
the Qiaprep column and drawn through using a vacuum manifold. 0.5ml of buffer PB
followed by 0.75ml of buffer PE were added to the column and washed through. The
column was then centrifuged for lmin at 14K rpm to remove residual PE. Finally 50pl of
buffer EB was added to the column, it was incubated at room temperature for lmin and
then centrifuged for lmin to elute the DNA into a fresh eppendorf tube.
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2.3.10 DNA sequencing
Sequencing was carried out using the ABI PRISM Dye Terminator Cycle Sequencing
Ready Reaction Kit based upon fluorescent chain termination. The sequencing reaction
was set up with 8.0ql of Terminator Ready Reaction Mix (ABI PRISM) O.lpg/ml of
double stranded DNA or 30ng/ml of PCR product, and 3.2pmole of primer in a final
reaction volume of 20pl. The sequencing reaction was then placed in the Applied
Biosystems GeneAmp PCR system 9700. The reaction was kept at 96°C for 30s, 50°C
for 15s and 60°C for 4 min and this was repeated for 25 cycles. The reaction was then
cooled to 4°C. The sequencing reaction was ethanol precipitated by adding 2ql 3M
sodium acetate (pH 4.6) and 50pl of 95% ethanol. This was vortexed and then spun at
20000 rpm for 40 min at 4°C. The ethanol was aspirated and replaced with 70% ethanol
and spun for a further 10 min. The 70% ethanol was aspirated and the pellet was left to
air dry. The sample was resuspended in 25pil of template suppression reagent (P/N
401674), vortexed, and spun. The sample was then heated at 95°C for two min to
denature the DNA, vortexed and spun again. Samples were then loaded into the ABI
PRISM 310 Genetic Analyser for sequencing.
2.4 Protein localisation and multimerisation experiments
2.4.1 Chemical cross-linking of protein
HEK cells were nucleofected with VAPB-GFP or VAPBP56S-GFP and incubated
overnight at 37°C. They were then treated with lOOmM to 250mM disuccinimidyl
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suberate (DSS) (Pierce) for lOmin. The cells were lysed in SDS loading dye and samples
were used for western blotting.
2.4.2 Triton X114 extraction (adapted from Bordier, 1981)
Cells were grown to the desired confluency (107 cells/cm2), trypsinised and then
harvested. The cells were then homogenised in 5ml of ice-cold 20mM Hepes (pH7.4),
320mM sucrose plus protease inhibitors (Boeringer). This was then centrifuged at 1500
rpm for 10 min at 4°C. The supernatant was decanted into another tube leaving the PI
pellet (consisting of cellular membranes such as the plasma membrane and nuclear
membrane). The supernatant or post nuclear fraction was centrifuged for a further 30
min at 20000 rpm to give the P2 (consisting of cellular membranes such as ER, Golgi and
intracellular vesicles) and S2 layers. The S2 layer was centrifuged for a further 90 min at
100000 rpm to give the P3 (possibly consisting of aggregated protein) and S3 (consisting
of soluble protein) layers. The P2 layer was resuspended in resuspension buffer and
incubated for 10 min on ice (or until cleared). The resuspended P2 was layered on to
300ml of sucrose cushion and then incubated at 30°C for 3 min. This was then
centrifuged at 300g for 3 min. The upper aqueous layer was removed and kept. 150ml of
10% Triton XI14 was centrifuged at 14000 rpm in a bench top centrifuge to remove the
remaining detergent phase.
All materials obtained from Sigma unless otherwise stated.
Resuspension buffer - lOmM Hepes pH 8.0 with KOH
400mM KC1
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1.0% Triton XI14 (BDH)
Sucrose cushion - 6%(w/v) Sucrose
lOmM Hepes pH 8.0
400mM KC1
0.06% Triton XI14 (BDH)
3. Yeast-two Hybrid Screen to identify MSP domain
interacting proteins
3.1 Background
VAPA and VAPB have three domains, the N-terminal MSP domain, a coiled-coil domain
and a hydrophobic tail domain (Nishimura et al., 1999). The coiled-coil domains of
VAPA and VAPB have been shown to interact with a variety of SNARE and fusion
proteins (Weir et al., 2001). However, a full screen of proteins interacting with the MSP
domains of these proteins has yet to be carried out. The MSP domain of the VAP
proteins shares a high level of homology with the major sperm protein first identified in
nematodes. The major sperm protein folds into an Ig-like domain, which is structurally
related to the periplasmic bacterial protein chaperone (PaPD).
In nematodes this protein has been shown to be involved in sperm locomotion in a role
analogous to that of actin in higher eukaryotic organisms. MSP forms filaments in
nematode sperm due to various interaction domains, which see it first form dimers and
then filamentous multimers (Baker et al., 2002). The formation of these filaments pushes
a vesicle formed from the plasma membrane forward at the leading edge of the
lamellipod causing sperm locomotion (Italiano et al., 1996). Other proteins involved in
the polymerization of MSP include a 48kDa membrane phosphoprotein (MPOP)
(LeClaire et al., 2003) and two MSP fibre proteins (MPF1 and MPF2) (Buttery et al.,
2003).
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More recently, MSP has been implicated in oocyte maturation and sheath cell contraction
in Caenorhabditis elegans (Miller et al., 2001). C. elegans oocytes are surrounded by
sheath cells, which they are coupled to via gap junctions. Sheath cell contraction drives
ovulation. VAB-1, a protein-tyrosine kinase is the only Eph receptor in C. elegans and it
negatively regulates oocyte M-phase entry. MSP acts as an antagonist of the VAB-1 Eph
receptor to give MAPK activation and oocyte meiotic maturation. It also antagonizes the
CEH-18 pathway, which acts in parallel with VAB-1 (Miller et al. 2003). However on
sheath cell membranes it may act as an agonist of the VAB-1 receptor and thus increase
sheath cell contraction. In order for MSP to regulate oocyte maturation it has to be
released from the sperm. However, sperm lack the cellular components required for
classical protein secretion, such as the ER, Golgi and ribosomes. Kosinski et al., have
recently discovered that spermatids and spermatozoa in C. elegans release MSP by a
novel vesicle-budding mechanism. Using TEM they visualized double membraned
vesicles containing MSP. These vesicles appeared to be labile and fuse to generate lipid
whorls as they disintegrate and release their contents (Kosinski et al., 2005).
Proteins, which contain MSP domains, are found in many other organisms such as S.
cerevisiae, Drosophila, Mus musculus and Homo sapiens. There are 7 mus musculus
proteins, which have been identified as containing a MSP domain (Figure 3.1).
These proteins include the VAP protein family, the motile sperm domain containing
proteins 1-4 (MOSPD1, MOSPD2, MOSPD3, MOSPD4) and hydin. MOSPD3 is a
protein with an MSP domain and two transmembrane domains and is very similar to
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MOSDP1. Using a gene trap vector MOSPD3 has been found to play a role in right
ventricle development in the heart (Pall et al., 2004). Hydin has been identified as
causing hydrocephalus in mice when a frameshift mutation is introduced. Hydrocephalus
is a net accumulation of cerebrospinal fluid in the ventricular system of the brain. As
hydin is specifically expressed in the choroids plexus and ependymal cells lining the
ventricles within the brain, dysfunction of these cells may play a role in the
hydrocephalus seen (Davy et al., 2003). MOSPD2 contains a flavin-containing
monooxygenase domain and can bind cellular retinaldehyde.
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Figure 3.1. Major Sperm Protein (MSP) homology domain of MSP-containing proteins
in the mouse.
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In the VAP proteins the MSP domain is the location of the binding site for the FFAT
(two phenylalanines in an acidic tract) motif of lipid binding proteins. Critical residues in
Mus musculus VAPA for FFAT binding are lysine-46, threonine-48, lysine-86 and
lysine-119. Modeled onto the known structure for C. elegans MSP the critical bases are
in a core peripherally surrounded by the non-critical bases (Loewen et al., 2005). While
VAPB and MOSPD4 share all the critical residues for FFAT motif binding in the mouse,
the other MSP domain proteins have only one or none of these bases, suggesting that they
do not bind proteins containing FFAT motifs (Table 3.1). Proteins containing FFAT
motifs that are known to bind to the VAP proteins thus far are all involved in lipid
synthesis.
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PROTEIN FFAT MOTIF
OSBP1 EFFDA
OSBPL2 EFFDA
OSBPL3 EFFDA
OSBPL4 EYFDA
OSBPL6 EFFDA
OSBPL9 EFYDA
NIR1 EFFDA
NIR2 EFFDA
NIR3 EFFDA
CERT EFFDA
PITPNM1 EFFDA
CHOREIN EFFDA
TESTIS SPERM
APOPTOSIS RELATED EFFDA
GENE 6 PROTEIN
HOMOLOGUE OF
DROSOPHILA RETINAL EFFDA
DEGENERATION B GENE
COG7 EFYDA
Table 3.1. Proteins containing a two phenylalanines in an acidic tract (FFAT) motif
mammals.
3.2 Yeast two-hybridprotein interaction screen using pGilda-
MSP
To determine which proteins the MSP domain of the VAPA protein could bind to and
interact with, a yeast two-hybrid screen using pGilda-MSP as the bait plasmid, and the
mouse brain LexA JG4-5 library as a target, was carried out. 4xl07 colonies were
screened in total and 115 potential positive transformants were found. Of these forty
colonies were established as X-gal positive colonies (Figure 3.2). These colonies were
then grown up and plasmid DNA was extracted. This plasmid DNA was then amplified
in KC8 cells and was extracted via miniprep. The library plasmid DNA was then
sequenced.
Of the forty colonies fifteen appeared after 48 hours and are presumed to be "strong
interactors", while twenty-five appeared after 72 hours and are "weaker interactors",
however the colonies that appear later may be slower to reach the nucleus and to activate
transcription (Table 3.2). Of the strong interactors fourteen colonies contained sufficient
target DNA for sequencing (Table 3.3). Of the weaker interactors nineteen colonies
contained sufficient target DNA for sequencing (Table 3.3).
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Figure 3.2. Yeast two-hybrid protein interaction screen. This is a Lex-A-based version of
the yeast two-hybrid system originally developed by Fields and Song. In the Lex-A
system the DNA binding protein (DB) is the E. coli Lex-A protein and the activation
protein (AP) is the acid blob domain B42. The DNA binding protein and the activation
protein cannot activate reporter expression on their own but when they are brought
together via two interacting proteins they activate ^-galactose reporter gene expression.
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Table 3.2. Growth analysis of positive clones. The yeast clones 1-40 (Yl-40) were
classified according to the time-point at which they appeared. "Strong interactors" with
the bait VAPA MSP protein appeared after 48 hours, whereas "Weak interactors"
appeared at 72 hours.
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GROWTH
CLONE 48hrs 72hrs
Y1 *
Y2 *
Y3 *
Y4 *
Y5 *
Y6 *
Y7 *
Y8 *
Y9 *
Y10 *
Yll *
Y12 *
Y13 *
Y14 *
Y15 *
Y16 *
Y17 *
Y18 *
Y19 *
Y20 *
Y21 *
Y21 *
Y23 *
Y24 *
Y25 *
Y26 *
Y27 *
Y28 *
Y29 *
Y30 *
Y31 *
Y32 *
Y33 *
Y34 *
Y35 *
Y36 *
Y37 *
Y38 *
Y39 *
Y40 . *
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Table 3.3. Sequencing analysis of the potential positive yeast colonies identified in the
yeast two-hybrid screen. A mixture of the bait and reporter plasmids along with the
mouse brain cDNA library plasmid was rescued from the yeast colony. This library
plasmid was then transformed into KC8 E. coli and selected for on ampicillin and -
Tryptamine LB plates. Library plasmid DNA was then obtained via miniprep from the
KC8 cells and sequenced on the ABI PRISM sequencer. A BLAST search was
performed for each sequence obtained on the Ensembl website.
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CLONE CORRESPONDING cDNA Length of clone DNA Coding sequence ofcDNA from Ensembl
Y1 TAF1 2953 -3876 1 - 3873
Y2
Good pasture antigen
binding protein (GPBP or
CERT
1294 - 2211 337 - 2211
Y3 OSBP1 1 - 990 169 - 2217
Y4
ZINC FINGER DHHC
DOMAIN CONTAINING
PROTEIN 7 (SERTOLI CELL
GENE WITH A ZINC FINGER
DOMAIN PROTEIN)
1 - 916 1 - 192
Y5 Rnfl44 422 - 1300 422 - 1300
Y6 ATF6a 1135 - 1710 2 - 2038
Y7
Good pasture antigen
binding protein (GPBP or
CERT
1294 - 2211 337 - 2211
Y8 Radl7 293 - 2067 293 - 2359
Y9 TAF1 2953 -3876 1 - 3873
Y10
No sequence gained due to
difficulties obtaining plasmid
DNA
Yll COG7 198 - 1152 3 - 2117
Y12 ATF6a 1135 - 1710 2 - 2038
Y13 DnaJal 112 - 918 112 - 1305
Y14 ORP9 269 - 1149 65 - 1929
Y15
GLUTAMATE
DEHYDROGENASE,
MITOCHONDRIAL
PRECURSOR(GDH)
889 - 1824 1 - 1821
Y16
No sequence gained due to
difficulties obtaining plasmid
DNA
Y17
No sequence gained due to
difficulties obtaining plasmid
DNA
Y18 ENSMUST00000092805 1 - 195 1 - 195
Y19 Rnfl44 422 - 1300 422 - 1300
Y20
ATP SYNTHASE DELTA
CHAIN, MITOCHONDRIAL
PRECURSOR
102 - 608 3 - 608
Y21 ENSMUST00000092805 1 - 195 1 - 195
Y22 Trappc4 248 - 907 248 - 907
Y23
GLUTAMATE
DEHYDROGENASE,
MITOCHONDRIAL
PRECURSOR(GDH)
889 - 1824 1 - 1821
Y24 pcdhbl3 1879 - 2454 1 - 2445
Y25
GLUTAMATE
DEHYDROGENASE,
MITOCHONDRIAL
PRECURSOR(GDH)
889 - 1824 1 - 1821
Y26 Psd4 2380 - 3188 171 - 3188
Y27
No sequence gained due to
difficulties obtaining plasmid
DNA
Y28 MOSPD2 1000 - 1669 113 - 1669
Y29 ENSMUSG00000031983 187 - 1155 187-1155
Y30 Q80TB9 1 - 759 1 - 3246
Y31 MOSPD4 1 - 576 1 - 576
Y32 MOSPD2 1000 - 1669 113 - 1669
Y33 Q80TB9 1 - 759 1 - 3246
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Y34 M0SPD2 1000 - 1669 113 - 1669
Y35 M0SPD4 1 - 576 1 - 576
Y36
ZINC FINGER DHHC
DOMAIN CONTAINING
PROTEIN 7 (SERTOLI CELL
GENE WITH A ZINC FINGER
DOMAIN PROTEIN)
1 - 916 1 - 192
Y37 ENSMUSG00000031983 187 - 1155 187-1155
Y38
No sequence gained due to
difficulties obtaining plasmid
DNA
Y39
No sequence gained due to
difficulties obtaining plasmid
DNA
Y40
No sequence gained due to
difficulties obtaining plasmid
DNA
3.3 Discussion
Of the sequences obtained from the yeast two-hybrid screen four of the proteins contain a
FFAT motif and therefore are predicted to interact with the MSP domain of VAPA.
These proteins include oxysterol binding protein 1 (OSBP1) and OSBP related protein 9
(ORP9), which are already known to interact with VAPA. Oxysterol binding protein
(OSBP) can interact with VAPA on the ER membrane via its FFAT motif.
Overexpression in CFIO cells of a PH domain mutant of OSBP that constitutively
interacted with VAPA formed unusual distensions of the ER that accumulated a
fluorescent ceramide analogue, unfolded vesicular stomatitis virus G protein-GFP and ER
chaperones such as PDI (Wyles et al., 2002). There are 12 members of the OSBP-related
protein (ORP) family and these proteins have 2 conserved motifs, a C-terminal OSBP
homology (OH) domain and an N-terminal PH domain. OSBP was originally identified
as a high affinity 25-hydroxycholesterol receptor (Dawson et al., 1989). 25-
hydroxycholesterol promotes rapid PH-domain-dependent translocation of OSBP to the
Golgi apparatus. Cholesterol and sphingomyelin have similar effects on OSBP
translocation suggesting that cellular lipid and cholesterol metabolism have an effect on
the cellular location of OSBP.
Of the ORP family OSBP and ORPs 1, 2, 3, 4, 6, 7 and 9 have been shown to interact
with VAPA. VAPA and VAPB have both been found to co-immunoprecipitate with
ORP 9. Compared to non-induced cells ORP 9 overexpression caused dramatic
reorganisation of ER and ERGIC compartments. VAPA was shifted from a reticular
pattern to the edges of numerous large vesicular structures that appeared in the cytoplasm
after induction of ORP 9 for 48 hours. Calnexin also localised to the same large vesicles,
as did ERGIC-53/p58, a marker for the ER-Golgi intermediate compartment. The
dramatic effect of ORP 9 and the VAPA-binding mutant on the distribution of
ERGIC53/p58 and Sec31 suggests that the COPII transport pathway may be affected
(Wyles et al., 2004).
Good pasture antigen binding protein (GPBP or CERT) is involved in the transfer of
ceramide between the ER and Golgi (Kuge et al., 1994) and conserved oligomeric Golgi 7
(COG7), a protein involved in Golgi associated membrane trafficking (Oka et al., 2005)
and these proteins also contain FFAT domains. Ceramide is synthesised in the ER and
then taken to the Golgi apparatus to be converted to sphingomyelin. Ceramide transfer
protein, CERT, is a protein that contains a Pi-binding pleckstrin homology (PH) domain,
and a putative lipid-transfer-catalysing domain named SMART. The PH domain targets
CERT to the Golgi by recognising PtdIns(4)P (Levine et al, 2004). CERT can
specifically extract ceramide from the ER via its START domain and is known to
catalyse the transfer of ceramide to donor membranes in vitro (Kuge et al., 1994).
There are other proteins with an FFAT domain that have been previously identified as
interacting with the MSP domain of VAPA. The reasons that they have not been detected
in this screen may be that not enough colonies were screened to pick up every interaction
of the VAPA MSP domain or that these proteins were of low abundance in the mouse
brain library used. Of the VAPA MSP domain interacting proteins not detected in the
screen the Nir protein family is of interest. Nirl, Nir2 and Nir3 are proteins expressed in
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the Golgi apparatus. Nir2 and Nir3 contain an N-terminal PI transfer domain, followed
by a short acidic region, 6 hydrophobic stretches and a highly conserved C-terminal
domain. The PI transfer domain has the ability to transfer PI and phosphatidylcholine
between membrane bilayers in vitro. Nirl, Nir2 and Nir3 all interact with VAPB.
Overexpression of wild-type Nir2 with VAPB caused production of large heterologous
granular structures that were dispersed around the nucleus throughout the cytosol. VAPB
expressed alone is a dimer but its interaction with Nir2 creates complexes of various sizes
that may represent different oligomerisation forms. Coexpression of Nirl and VAPB had
no apparent effect on either of their localisations. Coexpression of VAPB and Nir3
dramatically modified the organisation of microtubules. The microtubules were
unusually thick and not organised and the microtubule organisation centre was not
visible. The microtubule staining also aligned with the VAPB and Nir3 immunostaining.
It also reorganised the ER into a tubular structure (Amarilio et al., 2005). This is
particularly interesting as mouse VAPA is known to be involved in interactions with
microtubules (Skehel et al., 2000).
Three proteins containing a MSP domain were obtained in the screen MOSPD2,
MOSPD4 and Q80TB9 may interact with the VAPA MSP domain via their MSP domain.
Other proteins of note include activating transcription factor 6 (ATF6), one of the effector
proteins of the ER stress response (Ye et al., 2000) and deoxyribonucleic acid replication
factor with a J motif (DnaJ), a heat shock protein (Raabe et al., 1991). SCS2 is the yeast
homologue of VAPA and it has been found to be involved in the yeast ER stress response
(Kagiwada et al., 1998). ATF6 is a type II membrane protein and is cleaved by the site
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proteases SIP and S2P (Ye et al., 2000) in response to accumulation of unfolded proteins.
When cleaved in response to ER stress the bZIP containing N terminal half becomes a
soluble transcription factor and is translocated into the nucleus where it induces XBP-1
transcription (Yoshida et al., 2001). The cDNA clone found in the yeast two-hybrid
assay was only a partial clone containing the transmembrane domain of the protein and
parts of the luminal N terminal domain and the C terminal extra-luminal domain. As the
N terminus MSP domain of VAPA is extra-luminal, it is presumed that it would interact
with the C terminal portion of ATF6.
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4. The MSP domain and the ER stress response
4.1 Background
The VAP proteins are predominantly localized at the endoplasmic reticulum in Mus
musculus and Homo sapiens (Skehel et al., 2000). SCS2, the yeast homologue of VAPA,
is also a type II ER membrane protein. Yeast strains where the Scs2 gene has been
disrupted do not grow as well as wild-type strains in inositol-free medium and display
inositol auxotrophy (Kagiwada et al., 1998). SCS2 has been found to interact with OPI1
via its FFAT motif. OPI1 is a transcription factor, which regulates inositol transcription
(Loewen et al., 2003). This interaction binds OPI1 so that it cannot interact with INOl.
This releases Ino2 and Ino4 to activate inositol. The activation of HAC1 via the unfolded
protein response acts to release OPI1 from chromatin. This leaves INOl free to be
recruited to the nuclear membrane (Brickner et al., 2004). OPI1 can also bind to an
inhibitor, phosphatidic acid (PA), on the ER. Therefore, it can translocate to the nucleus
in response to consumption of PA by inositol (Loewen et al., 2004). As HAC1 is
important for the unfolded protein response (UPR) and INOl is important for ER
membrane biogenesis SCS2 plays a role in both of these pathways (Figure 4.1).
In the mammalian ER stress response three signalling cascades have been identified as
being important (Figure 4.2). These pathways are regulated by the activation of the
kinases IRE1 and PERK and also by the transcription factor ATF6 (Kaufman et al.,
2002). An increase in the amount of unfolded proteins in the ER causes activation of
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Figure 4.1 The Unfolded Protein Response (UPR) and phospholipid biosynthesis are
linked in yeast. The main components of the UPR in yeast are IRE1 and HAC1. As
increased biosynthesis of the ER would increase its capacity to handle unfolded proteins
it is unsurprising to find that these proteins can activate phospholipid biosynthesis via
OPIl.
87
Figure 4.2 The mammalian ER stress response has three main effector pathways. In
mammalian cells three proteins mediate the ER stress response, PERK, IRE1 and ATF6.
Both PERK and IRE1 are activated by dimerisation and autophosphorylation, while being
proteolysed activates ATF6. The activation of these proteins due to increased ER stress
leads to a reduction in general protein translation coupled by increased translation of
chaperone proteins via XBP-1 splicing to assist with protein folding. Inappropriate or
sustained activation of these ER stress effector proteins leads to apoptosis via CHOP
activation.
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IRE1 or PERK via dimerisation and autophosphorylation (Shamu et al., 1996). BiP, an
ER chaperone protein, is thought to regulate the activation of IRE1/PERK through
binding to these proteins when there are few unfolded proteins and preventing their
dimerisation (Kimata et al., 2003). IRE1 is a kinase/endonuclease, and is a type I ER
membrane protein (Tirasophon et al., 1998). IRE1 splices a small 26 nucleotide intron
from XBP-1 mRNA thus activating it. ATF6 is a bZIP protein, which is expressed as a
type II membrane protein in the ER and is activated by proteolysis by the site proteases
SIP and S2P (Ye et al., 2000). When cleaved in response to ER stress the bZIP
containing N terminal half becomes a soluble transcription factor and is translocated into
the nucleus where it induces XBP-1 transcription (Yoshida et al., 2001). As levels of
XBP-1 protein rise in the cell, genes, which have a UPR element (UPRE) or ER stress
response element (ERSE) in their promoters are induced. This leads to an increase in
chaperone proteins to assist in folding. Activation of PERK leads to translational
attenuation via phosphorylation of the eukaryotic initiation factor eIF2a (Okada et al.,
2002).
However, if the ER is still overloaded, the ER stress response can lead to apoptosis of the
cell mediated via a transcription factor or a caspase mediated pathway. IRE1 can
upregulate the transcription factor GADD153/CHOP and alter the balance between Bcl-2
and Bax (Wang et al., 1998, Ghribi et al., 2001) thus promoting apoptosis. In the second
pathway procaspase 12 could interact with IRE1 through the c-Jun-N terminal kinase
(JNK) pathway and the adaptor molecule TRAF2. Upon ER stress procaspase 12 is
released from TRAF2, homodimerises and undergoes auto-processing. Caspase 12
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translocates from the ER to the cytosol where it directly cleaves procaspase 9. Caspase 9
then activates the apoptosis effector caspase 3 (Yoneda et al., 2001).
XBP-1, the mammalian homologue of HAC1, has also been reported to be involved in
the biogenesis of the ER in NIH-3T3 fibroblasts (Sriburi et al., 2004). Mammalian
VAPA is known to interact with several oxysterol binding protein (OSBP) homologues
(Wyles et al., 2004) and with CERT, which is involved in ceramide transport (Hanada et
al., 2003). Therefore, the mammalian VAP proteins may be involved in ER membrane
biogenesis and the ER stress response. In this chapter we determine whether the major
sperm protein (MSP) domain of the VAP proteins can activate the mammalian ER stress
response.
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4.2 Overexpression of the VAP MSP domain fused to GFP
causes protein aggregation and neuronal cell death
The MSP domain of VAPA fused to GFP was transfected into primary hippocampal
cultured neurons from E19 rats as it had been noted previously that these cells appeared
to undergo cell death when transfected with this construct. MSP-GFP transfected
neurons had large aggregates of the GFP tagged protein as compared to GFP-alone
transfected controls. When VAPA was co-transfected into the hippocampal neurons with
DS.Red the red staining, which was throughout the cell, showed that the neuron was not a
typical shape with clear axons, but was a shrunken cell body with punctate axons like
those seen in dying neurons. This experiment was repeated with the VAPB MSP fused to
GFP, and again, large GFP protein aggregates were seen and DS.Red co-transfection
revealed atypical neuron morphology consistent with neuronal cell death (Figure 4.3A).
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling
(TUNEL) of DNA fragments was carried out on the primary hippocampal neurons
transfected with MSP-GFP or GFP alone (Loo et al., 1998). Neurons containing MSP-
GFP showed increased TUNEL staining as compared with GFP alone controls. This
indicates that MSP-GFP hippocampal neurons have increased DNA fragmentation due to
the chromosomal degradation seen in dying cells (Figure 4.3B).
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Figure 4.3. Increased TUNEL staining in primary hippocampal neurons expressing MSP-
GFP. A. The MSP domain of VAPA or VAPB fused to GFP or GFP alone was co-
transfected into El9 primary cultured hippocampal neurons along with a general cell
marker DS.Red. After 48 hours the neurons were imaged. The neurons expressing the
MSP constructs had large protein aggregates and did not appear to be healthy whereas
those transfected with GFP alone had diffuse staining and more normal morphology. B.
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling
(TUNEL) of DNA fragments was carried out on the primary hippocampal neurons
expressing MSP-GFP or GFP alone (n=3). As the representative figure shows neurons
containing MSP-GFP showed increased TUNEL staining as compared with GFP alone
controls.
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4.3 HEK293 cells expressing MSP-GFP also have large protein
aggregates and increased TUNEL staining
HEK293 cells expressing VAPA MSP-GFP were imaged 24 hours after transfection.
Large protein aggregates were seen of the GFP tagged MSP in these cells. TUNEL
staining also indicates that the transfected HEK293 cells showed increased TUNEL
staining as compared with non-transfected cells (Figure 4.4).
4.4 Overexpression of the MSP domain fused to GFP does not
change gross ER structure
VAPA fused to GFP and overexpressed in HEK293 cells colocalises with a DS.Red-ER
marker, which contains a calreticulin signal sequence and a KDEL sequence to localise it
to the ER compartment. The MSP domain of VAPA fused to GFP does not colocalise
with the DS.Red-ER marker so it is not localised to the ER. Overexpression of MSP-
GFP does not cause any gross changes in the ER compartment. This is true for MSP-
GFP overexpression in primary hippocampal neurons as well, where gross ER structure is
unchanged (Figure 4.5). This suggests that it is unlikely the cell death due to
overexpression of MSP-GFP is due to gross structural abnormalities in the ER
compartment.
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MSP-GFP TUNEL staining
Merge
Figure 4.4 Increased TUNEL staining in HEK293 cells expressing VAPA MSP-GFP.
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling
(TUNEL) of DNA fragments was carried out on HEK cells transfected with MSP-GFP.
HEK293 cells containing MSP-GFP showed increased TUNEL staining as compared
with non-transfected controls (n=3).
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DS.Red-ER HEK923 VAPA/DS.Red-ER HEK293 MSP-domain/DS.Red-ER HEK293
VAPA MSP DS.Red-ER neurons
Figure 4.5 No gross ER disruption in cells expressing MSP-GFP. HEK cells or E19
primary cultured hippocampal neurons were transfected with VAPA-GFP and DS.Red-
ER, VAPA MSP-GFP and DS.Red-ER or DS.Red-ER alone. No gross changes in ER
structure were seen in any of these cells (n=6).
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4.5 Production of tetracycline inducible MSP-GFP and GFP
stable cell lines
As biochemical assays on the primary hippocampal neurons would have been difficult
due to a less than 5% transfection rate of MSP-GFP with calcium phosphate and a less
than 20% transfection rate with lipofectamine, and the short time course of MSP-GFP
transfected cell death, it was decided to make an inducible stable cell line on which to
perform these studies. VAPA MSP-GFP and GFP were cloned into pcDNA4/TO, an
expression vector under the transcriptional control of tetracycline. HEK293 cells that
stably express the tetracycline repressor pcDNA6/TR (Trex cells), were transfected with
MSP-GFP/TO and GFP/TO. 48 hours after transfection, zeocin was added to the cells at
a concentration of 50pg/ml. 1 week after this point stable colonies were found on the
plate. These colonies were picked and grown for a further week. Of 4 colonies, which
grew well and contained the repressor, 4 were found to express reasonable levels of
MSP-GFP and all further studies were carried out on clone 2 (Figure 4.6A). The GFP
stable cell line was generated in the same manner (Figure 4.7A). Protein aggregates were
seen in the tetracycline-induced (lpg/ml) MSP-GFP cells after 48 hours of induction, no
aggregates were observed in the GFP cells after the same amount of time. Western blots
were carried out on both cell lines to confirm expression of proteins of the correct size
(Figures 4.6B and 4.7B).
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24 hours induction 48 hours induction
Figure 4.6. HEK293 tetracycline inducible cell line expressing MSP-GFP gives large
protein aggregates. A. A stable tetracycline-inducible HEK cell line expressing VAPA
MSP-GFP was made. These cells contained large protein aggregates at 48 hours when
imaged on a fluorescent microscope. B. Protein extracts were taken of these cells at 0, 2,
4, 6, 24, and 48 hours after tetracycline addition. Western blotting of these extracts
showed maximal induction of MSP-GFP protein at 4 hours after tetracycline induction of
protein transcription.
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Figure 4.7. HEK293 tetracycline inducible cell line expressing GFP. A. A stable
tetracycline-inducible HEK cell line expressing GFP was made. These cells had strong
diffuse GFP expression at 48 hours when imaged on a fluorescent microscope. B.
Protein extracts were taken of these cells at 0, 2, 4, 6, and 24 hours after tetracycline
addition. Western blotting of these extracts showed maximal induction of GFP protein at
24 hours after tetracycline induction of protein transcription.
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4.6 MSP-GFP cells show no growth after induction of protein
expression
A growth assay was carried out upon MSP-GFP uninduced cells, MSP-GFP cells induced
with lp,g/ml tetracycline, and Trex cells only containing pcDNA6/TR treated with
lpg/ml tetracycline. Cells in 4 defined boxes in each well were counted. This was
repeated for 3 wells of each of induced MSP-GFP, uninduced MSP-GFP and tetracycline
treated Trex cells at the point of tetracycline addition (day 1), and then at 24 (day 2), 48
(day 3) and 72 (day 4) hours. The results for each well were averaged and the percentage
of cell growth was calculated along with the standard deviation. Both the uninduced
MSP-GFP cells and the tetracycline treated Trex cells grew normally. However the
induced MSP-GFP cells did not grow at all and there were less cells sticking to the cell
plate, i.e. those that were healthy, after 72 hours of induction than there were to begin
with (Figure 4.8). This experiment was repeated with the inducible GFP cell line and it
was observed that both induced and uninduced GFP cells grew at the same rate (Figure
4.9). This data shows that induction of the expression of the MSP-GFP protein inhibits
cell growth in HEK293 cells and may induce cell death.
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MSP-GFP Cell Growth
Figure 4.8 HEK293 tetracycline inducible cell line expressing MSP-GFP shows no cell
growth. Stable MSP-GFP cells and Trex (HEK cells expressing pcDNA6/TR) cells were
seeded at a low density into 6 well plates. Half of the MSP-GFP cells and the Trex cells
were treated with lpg/ml tetracycline. At 0, 24, 48 and 72 hours after tetracycline
treatment the number of cells in a boxed area of the each well was counted with 4 marked
boxes counted in each well at each timepoint. The number of cells in each well and
between the wells with the same cells and treatment were averaged for each timepoint.
While uninduced MSP-GFP cells and tetracycline treated Trex cells grew normally,
induced MSP-GFP cells did not grow at all and may even be undergoing cell death (n=3).
100
Figure 4.9 HEK293 tetracycline inducible cell line expressing GFP shows normal cell
growth. Stable GFP cells were seeded at a low density into 6 well plates. Half of the
GFP cells were treated with lpg/ml tetracycline. At 0, 24, 48 and 72 hours after
tetracycline treatment the number of cells in a boxed area of the each well was counted
with 4 marked boxes counted in each well at each timepoint. The number of cells in each
well and between the wells with the same cells and treatment were averaged for each
timepoint. Both induced and uninduced GFP cells grew at the same rate (n=3).
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4.7 Induced MSP-GFP cells have increased propidium iodide
staining compared to control cells
To confirm that the induced MSP-GFP cells were undergoing cell death a vital dye,
propidium iodide was used. When cells are dying their cell membrane becomes more
permeable and there is increased up-take of small molecules such as propidium iodide.
As before induced MSP-GFP, uninduced MSP-GFP, and tetracycline treated Trex cells
were counted. lp,g/ml of tetracycline was added to the cells and 24 hours later they were
treated with 5pl/ml propidium iodide for 20 minutes and imaged and counted
immediately (day 1). The propidium iodide staining was repeated on a different set of
cells at 48 hours after tetracycline addition (day 2). The results for each well were
averaged and the percentage of propidium iodide containing cells was calculated along
with the standard deviation in the sample. The uninduced MSP-GFP cells and the
tetracycline treated Trex cells had an extremely small percentage of propidium iodide
stained cells at 24 and 48 hours. However, the induced MSP-GFP cells showed
significantly higher levels of propidium iodide staining at 24 hours (42.1 + 18.3%) and at
48 hours (75.9 + 27.2%) (Figure 4.10). This indicates that induction of MSP-GFP
protein expression in HEK cells causes cell death.
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Figure 4.10 HEK293 tetracycline inducible cell line expressing MSP-GFP undergoes cell
death. Stable MSP-GFP cells and Trex (HEK cells expressing pcDNA6/TR) cells were
seeded at a low density into 6 well plates. Half of the MSP-GFP cells and the Trex cells
were treated with lpg/ml tetracycline. All of the cells were treated with 5pg/ml
propidium iodide. At 24 and 48 hours after tetracycline treatment the number of red or
propidium iodide containing cells in a boxed area of the each well was counted with 4
marked boxes counted in each well at each timepoint and divided by the total number of
cells in each boxed area to determine the percentage of red cells. The number of cells in
each well and between the wells with the same cells and treatment were averaged for
each timepoint. While the Trex plus tetracycline and uninduced MSP-GFP cells
contained very few propidium iodide stained and therefore dying cells, the induced MSP-
GFP cells showed a high percentage of dying cells at 24 hours and almost all of them
were dead at 48 hours (n=3).
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4.8 DNA laddering in induced MSP-GFP HEK cells indicates
apoptotic cell death
In order to determine whether the cell death seen in the induced MSP-GFP cells was
apoptotic or necrotic a DNA laddering experiment was carried out. Dithiothreitol (DTT)
reduces formation of disulphide bonds and causes retention of proteins in the ER and ER
stress (Jamsa et ai., 1994), and if the ER is under stress for long enough the cell will
undergo apoptosis. Therefore, addition of lOmM DTT for 48 hours was the positive
control for DNA laddering due to apoptosis. Trex cells treated with tetracycline and
uninduced MSP-GFP cells showed no DNA laddering when run on a 2% agarose gel.
However, the MSP-GFP cells, which had been induced for 48 hours, showed significant
DNA laddering comparable to that seen with the Trex cells treated with DTT (Figure
4.11). This indicates that the cell death seen in the stable MSP-GFP cell line is apoptotic
in nature.
4.9 HEK cells transiently transfected with MSP-GFP and VAPA
have upregulated levels ofBiP mRNA
To determine whether MSP-GFP protein expression in HEK293 cells activates apoptotic
pathways, via the ER stress response, a northern blot was carried out on transiently
transfected HEK293 cells. Tissue plasminogen activator (t-PA) is a serine protease and
its expression in A. niger leads to transcriptional up-regulation of genes encoding the ER
chaperones and foldases BIPA, CYPB and PDIA (Wiebe et al., 2001).
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Figure 4.11 HEK293 tetracycline inducible cell line expressing MSP-GFP undergoes
DNA laddering, indicative of apoptosis. DNA extracts of MSP-GFP cells induced for 0
and 48 hours with 1 pg/ml tetracycline, Trex cells and Trex cells treated with lOmM
Dithiothreitol (DTT) for 48 hours were taken and run on a high percentage agarose gel.
The Trex cells and the uninduced MSP-GFP cells showed no DNA laddering whereas the
Trex cells treated with DTT and the induced MSP-GFP cells both showed DNA
laddering indicative of apoptotic cell death (n=2).
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Figure 4.12 (contributed by Paul Skehel). HEK293 tetracycline inducible cell line
expressing MSP-GFP has increased BiP mRNA production. HEK293 cells were
transiently transfected with VAPA-GFP, tPA-GFP, GFP, inducible MSP-GFP, BFP and a
no-DNA control. RNA extracts were prepared and the Northern blot shows that tPA-
GFP, MSP-GFP and VAPA-GFP transfected cells have higher levels of BiP mRNA
compared with controls.
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In HEK293 cells t-PA also increases BiP mRNA levels, hence it was used as a positive
control. GFP, BFP, sham (calcium phosphate treated) and MSP-GFP/TO uninduced
HEK cells showed no increase in the levels of BiP mRNA. MSP-GFP and full-length
VAPA transfected cells showed increases in the levels of BiP mRNA (Figure 4.12). As
previously mentioned, full length VAPA is a type II membrane protein, which resides in
the ER, facing out of the ER lumen into the cytoplasm. The overexpression of various
ER proteins facing into the lumen have been found to increase ER stress, hence the
overexpression of VAPA may also shift ER dynamics and increase ER stress as it resides
in the ER. However, MSP-GFP does not reside in the ER, as it has no transmembrane
domain so it may affect ER stress pathways via protein interactions or a signaling
function.
4.10 Phospho-PERK and caspase 3 levels are increased in
induced MSP-GFP cells
To confirm the involvement of ER stress pathways in the MSP-GFP induced apoptosis
other effector proteins in this pathway were studied by western blot. PERK is a key
effector protein in this pathway and there is a clear increase in PERK phosphorylation at
Thr980 after 2 hours of MSP-GFP protein expression, which lasts until 24 hours (Figure
4.13). This is similar to the levels seen with treatment with 1 pig/ptl tunicamycin, which
inhibits N-Iinked glycosylation of proteins and so increases ER stress (Welihinda et al.,
1999). However, no phosphorylated PERK is seen in the induced GFP cells even after 24
hours of induction (Figure 4.14). Caspase 3 is also involved in the end stages of ER
stress induced apoptosis and at 6 hours activated caspase 3 is found in the induced MSP-
GFP cells (Figure 4.13). The activation of these ER stress proteins in the induced MSP-
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GFP cells demonstrates that the ER stress response is activated by the induction of MSP
domain protein expression and is responsible for the activation of apoptotic proteins.
109
Western with phosphoPERK antibody
180 kDa
17kDa
30kDa
■' j- '
-fmn,... .
Western with Caspase 3 antibody
■■■I
mm * • - I
VAPA endogenous control
£ £ £ £ 2 £
oo 00 00 00 00 00
73 ^d 73 73 73 73
i
6 6 6 6 6 Q
TI 71 71 71 71 71
% 73 73 ^d 7d
K> f3 4^
s—' w' s' 4^ 00
H H
i-» i—$
a> o
X x
+
H
K>
Figure 4.13 HEK293 tetracycline inducible cell line expressing MSP-GFP has increased
phospho-PERK and caspase 3 production. Protein extracts were taken of the MSP-GFP
cells at 0, 2, 4, 6, 24 and 48 hours after 1 pg/ml tetracycline addition and of Trex cells
and Trex cells treated with tunicamycin for 24 hours. Western blotting of 20pg of these
extracts showed that PERK was maximally phosphorylated after 2-4 hours of MSP-GFP
expression while caspase 3 was activated after 24-48 hours of MSP-GFP expression
(n=5).
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Figure 4.14 Confirmation that HEK293 tetracycline inducible cell line expressing MSP-
GFP has increased phospho-PERK production. Protein extracts were taken of the MSP-
GFP and GFP cells at 0, 2, 4, 6 and 24 hours after 1 pg/ml tetracycline addition and Trex
cells treated with tunicamycin for 24 hours. Western blotting of these extracts showed
that PERK was maximally phosphorylated after 4-6 hours of MSP-GFP expression
whereas no phosphorylation of PERK is seen in the induced GFP cells at any timepoint
(n=2).
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4.11 Discussion
VAPA and VAPB are known to reside on the ER (Skehel et al., 2000), which is the
organelle responsible for protein translation, protein folding and post-translational protein
modifications. We have discovered that when the MSP domain of VAPA is expressed
without the coiled-coil or tail domains in both HEK293 cells and primary cultured
hippocampal neurons, these cells undergo apoptotic cell death due to inappropriate
activation of the ER stress response.
The MSP domain tagged with GFP expressed in either HEK293 cells, or primary
hippocampal neurons, formed large intracellular protein aggregates. The MSP domain
was toxic to these cell types and transfected HEK cells died within 48 hours. In a stably
induced MSP domain cell line large protein aggregates formed within 24 hours but were
not present before this time point. However, phosphoPERK induction was evident at 2
hours after induction when there was MSP protein present but no large aggregates had
formed. The induction of BiP mRNA transcription and PERK phosphorylation are
indicative of ER stress response activation, as is the induction of caspase-3 leading to
apoptotic cell death. It is likely that the MSP domain disrupts ER stress signalling in
some manner.
The MSP domain of the VAP proteins folds into an Ig-like domain, which is structurally
related to PaPD, a bacterial chaperone. This domain is predicted to be involved in
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protein-protein interactions. VAPA can dimerise and is thought to interact via both its
coiied-coil and tail regions but does not dimerise via its MSP domain (Kaiser et al.,
2005). Therefore it is unlikely that the MSP domain is interacting with the endogenous
VAPA or VAPB but may be influencing ER stress signalling via other protein
interactions.
The yeast homologue of VAPA, SCS2, is known to be involved in the yeast ER stress
response (Loewen et al., 2003) and in yeast ER membrane biogenesis. VAPA and VAPB
may play a similar role in humans.
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VAPA AND VAPB
5.1 Background
Mouse VAPA is known to be an ER protein, which is integral to the ER membrane and in
a type II orientation (Skehel et al., 1995). Mouse VAPB had not yet been cloned at the
beginning of these studies. In order to determine whether VAPA and VAPB were
identical in structure and function, VAPB was cloned, and various cDNA truncation
constructs were generated and expressed in HEK293 cells so that protein localisation and
function could be studied.
114
5.2 Cloning and gross cellular localisation of VAPB
The proteins VAPA and VAPB show a high degree of homology in the MSP domain but
show a much lower degree of homology in the coiled-coil and tail regions (Figure 5.1).
To determine whether VAPB had a similar localisation pattern as VAPA it was cloned
from a mouse cDNA library and ligated into EGFP-C1. This construct was transfected
into HEK293 cells and primary cultured rat (E19) hippocampal neurons on its own and
co-transfected with DS.Red-ER, which is targeted to the ER membrane. VAPB has a
similar gross distribution to VAPA and colocalises with the DS.Red-ER marker (Figure
5.2). This data demonstrates that VAPB is localised on the ER in both HEK cells and in
hippocampal neurons.
5.3 VAPA and VAPB antibody staining colocalises on the ER
To examine the localisation patterns in more detail specific VAPA and VAPB antibodies
were used to stain HEK293 cells. HEK293 cells were plated onto coverslips, fixed and
stained with a specific VAPA antibody, followed by a specific VAPB antibody. The two
marker show a high degree of colocalisation on the ER as shown by the yellow staining
of the merged signals (Figure 5.3).
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Figure 5.1 VAP family homology. VAPA and VAPB have very similar MSP domains.
Their coiled-coil domains and hydrophobic tails show a much smaller degree of
homology. Both VAPA and VAPB contain conserved residues responsible for FFAT
motif binding. VAPC, a splice variant of VAPB, does not contain all of these residues so
may not bind FFAT-containing proteins.
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A B
HEK293 Cells Primary cultured neurons (E19)
VAPA-GFP VAPB-GFP VAPA-GFP VAPB-GFP
VAPA-GFP/DS.Red-ER VAPB-GFP/DS.Red-ER VAPA-GFP/DS.Red-ER VAPB-GFP/DS.Red-ER
Figure 5.2 VAPA and VAPB colocalise predominantly with ER markers in primary
hippocampal neurons and HEK293 cells. HEK293 cells and E19 primary hippocampal
cultured neurons were transfected with VAPA-GFP or VAPB-GFP with or without
DS.Red-ER. Both VAPA and VAPB predominantly colocalise with the DS.Red-ER
marker (n=6).
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VAPB co-localisation VAPA
Figure 5.3 Colocalisation of VAPA and VAPB. HEK cells were plated on glass
coverslips coated with poIy-D-lysine and then fixed. The coverslips were treated with
specific VAPA and VAPB antibodies. The VAPA and VAPB staining shows that there
is a significant amount of co-localisation (yellow) (n=6).
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5.4 Fractionation and Triton X114 extraction of VAPA and VAPB
demonstrates differences in membrane association
To elucidate whether VAPA and VAPB were in biochemically distinct areas of the ER
Triton XI14 extractions were carried out. PI, P2, S2, P3 and S3 fractions were prepared
from HEK293 cells as described in the materials and methods. Using this method VAPB
was identified as being essentially soluble in contrast to VAPA, as most of VAPA was
pelleted at P2 whereas VAPB was not completely pelleted at P3 (Figure 5.4A). When the
P2 layer of the HEK293 cells was detergent extracted with Triton XI14 (Bordier et al.,
1981) VAPA was extracted into the detergent indicating that it is lipophilic. However,
VAPB was not extracted into the detergent and remained in the aqueous layer indicating
that VAPB hydrophilic (Figure 5.4B). It also highlights differences in the hydrophobicity
of VAPA and VAPB, which may be important in their interactions with lipids and lipid
binding proteins.
5.5 VAPA and VAPB MSP constructs Triton X114 extract
differently
Various truncation constructs of VAPA and VAPB were then generated to determine
which domains were responsible for their differing localisations. The VAPA and VAPB
MSP constructs (Figure 5.5) were transiently transfected into HEK293 cells and PI, P2,
and S2 layers prepared as described in the materials and methods.
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Figure 5.4 Fractionation and Triton XI14 extraction of endogenous VAPA and VAPB in
HEK293 cells. A. HEK cells were lysed and PI, P2, S2, P3 and S3 layers were
prepared. lOmg of PI, P2 and S2 were run on the gel and 20mg of P3 and S3 were run.
Specific VAPA and VAPB antibodies were used to probe the extracts on a western blot.
This revealed that VAPA was present predominantly in the heavier fractions PI and P2,
while VAPB was also present in the lighter fractions P3 and S3. B. The P2 layer of the
HEK cells was detergent extracted using Triton XI14. This reveals that VAPA is mainly
detergent extracted while VAPB is found in the aqueous layer (n=3).
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Figure 5.5 Truncation constructs of VAPA and VAPB.
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The P2 layer was detergent extracted (Bordier et al., 1981) with Triton XI14 and the
samples were analysed by western blots probed with GFP antibody. As described in the
previous chapter both the VAPA and VAPB MSP-GFP construct form large protein
aggregates in HEK293 cells at this timepoint and these aggregates do not co-localise with
the DS.Red-ER marker (Figure 5.6A and 5.7A). The VAPA MSP domain was mostly
found in the soluble fraction and in the aqueous layer when Triton XI14 extracted which
is consistent with it being in the cytoplasm (Figure 5.6B). The VAPB MSP domain was
mostly found in the P2 layer and was roughly 50% detergent extracted (Figure 5.7B).
This could be due to strong interactions with an ER protein.
5.6 VAPA and VAPB coiled-coil domains are cytoplasmic
The VAPA and VAPB coiled-coil constructs fused to GFP have a diffuse distribution in
HEK cells similar to that of GFP expressed alone. Consistent with a diffuse cytoplasmic
distribution they are found almost exclusively in the S2 fraction (Figure 5.8 and 5.9).
5.7 Triton X114 extraction reveals that the tail region of both
VAPA and VAPB are sufficient to target the protein to the
correct ER subdomain
The VAPA and VAPB tails expressed on their own gave the same subcellular distribution
as the endogenous VAPA and VAPB (Figure 5.10 and 5.11). However these tail
domains contain a GxxxG domain predicted to be involved in transmembrane helix-helix
association (Russ et al., 2000).
122
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B
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Figure 5.6 Triton XI14 extraction of HEK293 cells, expressing VAPA MSP-GFP. A.
VAPA MSP-GFP was transiently transfected into HEK cells along with DS.Red-ER and
the cells were imaged after 48 hours. The VAPA MSP-GFP does not co-localise with the
DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2 layers were prepared.
The P2 layer of the HEK cells was detergent extracted using Triton XI14. VAPA MSP-
GFP is found mainly in the S2 layer (n=3).
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Figure 5.7 Triton XI14 extraction of HEK293 cells, expressing VAPB MSP-GFP. A.
VAPB MSP-GFP was transiently transfected into HEK cells along with DS.Red-ER and
the cells were imaged after 48 hours. At this timescale all of the VAPB MSP-GFP cells
were dying so it was not possible to determine its cellular localisation. B. HEK cells
were lysed and PI, P2, and S2 layers were prepared. The P2 layer of the HEK cells was
detergent extracted using Triton XI14. VAPB MSP-GFP is found predominantly in the
P2 layer and is partially detergent extracted in Triton XI14 (n=3).
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Figure 5.8 Triton XI14 extraction of HEK293 cells, expressing VAPA coiled-coil-GFP.
A. VAPA coiled-coil-GFP was transiently transfected into HEK cells along with DS.Red-
ER and the cells were imaged after 48 hours. VAPA coiled-coil-GFP partially co-
localises with the DS.Red-ER marker but in general its distribution is much more diffuse.
B. HEK cells were lysed and PI, P2, and S2 layers were prepared. The P2 layer of the
HEK cells was detergent extracted using Triton XI14. VAPA coiled-coil-GFP is found
mainly in the S2 layer (n=3).
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Figure 5.9 Triton XI14 extraction of HEK293 cells, expressing VAPB coiled-coil-GFP.
A. VAPB coiled-coil-GFP was transiently transfected into HEK cells along with DS.Red-
ER and the cells were imaged after 48 hours. VAPB coiled-coil-GFP did not co-localise
with the DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2 layers were
prepared. The P2 layer of the HEK cells was detergent extracted using Triton XI14.
VAPB coiled-coil-GFP is found predominantly in the S2 layer (n=3).
126
VAPA TAIL
203
NH2 —
243
- COOH
VAPA Tail-GFP Merge DS.Red-ER
B
PI P2 S2 D AQ
Figure 5.10 Triton XI14 extraction of HEK293 cells, expressing VAPA Tail-GFP. A.
VAPA Tail-GFP was transiently transfected into HEK cells along with DS.Red-ER and
the cells were imaged after 48 hours. VAPA Tail-GFP completely co-localises with the
DS.Red-ER marker. B. F1EK cells were lysed and PI, P2, and S2 layers were prepared.
The P2 layer of the HEK cells was detergent extracted using Triton XI14. VAPA Tail-
GFP is found mainly in the P2 layer and is detergent extracted in Triton XI14 (n=3).
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Figure 5.11 Triton XI14 extraction of HEK293 cells, expressing VAPB Tail-GFP. A.
VAPB Tail-GFP was transiently transfected into HEK cells along with DS.Red-ER and
the cells were imaged after 48 hours. VAPB Tail-GFP completely co-localised with the
DS.Red ER marker. B. HEK cells were lysed and PI, P2, and S2 layers were prepared.
The P2 layer of the HEK cells was detergent extracted using Triton XI14. VAPB Tail-
GFP is found predominantly in the S2 layer (n=3).
128
Therefore the tail domains may be targeted to the correct ER subdomain via specific
interactions with endogenous VAPA or VAPB. When VAPA Tail-GFP and DS.Red-
VAPB Tail are co-expressed in HEK cells, a similar distribution is seen to that of
endogenous VAPA and VAPB (Figure 5.12).
5.8 VAPA and VAPB expressed without the tail domain have
different cellular localisations
The VAPA and VAPB constructs without the tail domains appear to have different
cellular localisations. VAPA without the tail has a diffuse distribution similar to that of
the coiled-coil domain expressed alone. VAPB without the tail, however, largely co-
localises with the DS.Red-ER marker although this co-localisation is not as great as that
of full-length VAPB. This construct is definitively excluded from the nucleus however,
whereas VAPA without the tail is not. The constructs do not have the tail domain to
insert them into the ER membrane and this is confirmed by neither of them being
detergent extracted in Triton XI14 (Figure 5.13 and 5.14). The differences in localisation
seen may be due to differing protein interactions.
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Figure 5.12 VAPA and VAPB tail comparison. A. VAPA Tail-GFP was transiently
transfected into HEK cells along with DS.Red-VAPB Tail and the cells were imaged
after 48 hours. VAPA Tail-GFP and DS.Red-VAPB-Tail partially co-localise in HEK
cells. B. VAPA and VAPB Tail homology (n=6).
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Figure 5.13 Triton XI14 extraction of HEK293 cells, expressing VAPA-GFP without
Tail. A. VAPA-GFP without Tail was transiently transfected into HEK cells along with
DS.Red-ER and the cells were imaged after 48 hours. VAPA-GFP without Tail does not
co-localise with the DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2
layers were prepared. The P2 layer of the HEK cells was detergent extracted using Triton
XI14. VAPA-GFP without Tail is found mainly in the S2 layer and is not detergent
extracted in Triton XI14 (n=3).
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Figure 5.14 Triton XI14 extraction of HEK293 cells, expressing VAPB-GFP without
Tail. A. VAPB-GFP without Tail was transiently transfected into HEK cells along with
DS.Red-ER and the cells were imaged after 48 hours. VAPB-GFP without Tail partially
co-localised with DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2 layers
were prepared. The P2 layer of the HEK cells was detergent extracted using Triton
XI14. VAPB-GFP without Tail is found predominantly in the S2 layer (n=3).
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5.9 VAPA and VAPB expressed without the MSP domains co-
localise with DS.Red-ER and are in similar fractions
Both VAPA and VAPB expressed without their MSP domain co-localise with the
DS.Red-ER marker. When fractions of these constructs are made they are found in both
the P2 and S2 layers at a similar volume. The protein found in the S2 layer appears in
two bands of slightly different sizes. This may indicate proteolysis of these constructs,
presumably at the c-terminal end of the protein as they are N-terminally tagged with GFP
and the smaller fragment would not be picked up if it were N-terminally cleaved (Figure
5.15 and 5.16).
5.10 VAPA with the tail replaced with the VAPB tail localises to
the same ER subdomain as endogenous VAPB
The VAPB tail construct was removed from the GFP vector by restriction digest and
inserted into the VAPA without a tail construct, to give VAPA with the VAPB tail. This
construct had a gross ER distribution when imaged as it colocalised with the DS.Red-ER
marker. When fractionated and extracted with Triton XI14 it shared the same subdomain
localisation as endogenous VAPB (Figure 5.17). Therefore no other part of the protein
appears to affect subdomain localisation, which is determined by the tail alone.
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Figure 5.15 Triton XI14 extraction of HEK293 cells, expressing VAPA coiled-coil with
Tail-GFP. A. VAPA coiled-coil with Tail-GFP was transiently transfected into HEK
cells along with DS.Red-ER and the cells were imaged after 48 hours. VAPA coiled-coil
with Tail-GFP completely co-localised with the DS.Red-ER marker. B. HEK cells were
lysed and PI, P2, and S2 layers were prepared. The P2 layer of the HEK cells was
detergent extracted using Triton XI14. VAPA coiled-coil with Tail-GFP is found in the
P2 and S2 layers and is detergent extracted in Triton XI14.
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Figure 5.16 Triton XI14 extraction of HEK293 cells, expressing VAPB coiled-coil with
Tail-GFP. A. VAPB without MSP-GFP was transiently transfected into HEK cells along
with DS.Red-ER and the cells were imaged after 48 hours. VAPB coiled-coil with Tail-
GFP completely co-localised with DS.Red-ER marker. B. HEK cells were lysed and PI,
P2, and S2 layers were prepared. The P2 layer of the HEK cells was detergent extracted
using Triton XI14. VAPB coiled-coil with Tail-GFP is found in the P2 and S2 layers.
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Figure 5.17 Triton XI14 extraction of HEK293 cells, expressing VAPA with B Tail-
GFP. A. VAPA with B Tail-GFP was transiently transfected into HEK cells along with
DS.Red-ER and the cells were imaged after 48 hours. VAPA with B Tail-GFP
completely co-localises with the DS.Red-ER marker. B. HEK cells were lysed and PI,
P2, and S2 layers were prepared. The P2 layer of the HEK cells was detergent extracted
using Triton XI14. VAPA with B Tail-GFP is found predominantly in the S2 layer
(n=3).
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5.11 Variant of VAPB found in humans, VAPC may also be
present in mice.
VAPC is a splice variant of VAPB, which has been previously identified in humans by
northern blot (Nishimura et al., 1999). VAPC contains exons 1, 2 and 6 of VAPB
therefore it contains almost the entire MSP domain and a short sequence of C terminal
which is not homologous to either VAPA or VAPB. Using specific PCR primers a 300
base pair PCR product was made form a mouse brain cDNA library along with a band
corresponding to full length VAPB (Figure 5.18). However this band has yet to be
cloned and sequenced. Therefore the mouse may also contain the splice variant of VAPB
named VAPC.
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Figure 5.18 PCR band of correct size for VAPC in the mouse.
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VAP mutant Cell localisation
Fraction present in
PI P2 S2 D AQ
ENDOGENOUS
VAPA
endoplasmic
reticulum
Y 80% 20% 90% 10%
ENDOGENOUS
VAPB
endoplasmic
reticulum
Y 20% 80% 100%
VAPA
MSP
cytosolic aggregates Y 30% 70%
VAPB
MSP cytosolic aggregates
Y 90% 10% 50% 50%
VAPA COILED
COIL
diffuse cytosolic Y 100%
VAPB COILED
COIL
diffuse cytosolic Y 5% 95%
VAPA
TAIL
endoplasmic
reticulum
Y 80% 20% 95% 5%
VAB
TAIL
endoplasmic
reticulum
Y 20% 80% 50% 50%
VAPA WITHOUT
TAIL
diffuse cytosolic Y 10% 90% 5% 95%
VAPB WITHOUT
TAIL
endoplasmic
reticulum
Y 10% 90% 5% 95%
VAPA COILED
COIL WITH TAIL
endoplasmic
reticulum
Y 60% 40% 100%
VAPB COILED
COIL WITH TAIL
endoplasmic
reticulum
Y 50% 50%
VAPA WITH
VAPB TAIL
endoplasmic
reticulum
Y 5% 95%
Table 5.1 Differences in localisation of YAP truncation constructs.
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5.13 Discussion
The VAP family of proteins appears to play a major role in the localisation of oxysterol
and other lipid binding proteins to the ER, as well as in sensing ER stress. We have
identified differences in the subcellular localisation of VAPA and VAPB on the ER
membrane.
VAPA localises like an integral ER protein and pellets mostly in the P2 layer, and is in
the detergent phase in Triton XI14. VAPB, however, does not pellet as well into the P2
layer, suggesting that it is in lighter membrane fractions and is in the aqueous phase in
Triton XI14 suggesting that it is not an integral membrane protein. These differences are
surprising as VAPA and VAPB share a high degree of homology.
To determine which domains were responsible for the differences in VAPA and VAPB
localisation we made a variety of truncations of the VAP proteins. This revealed that the
tail region of VAPA was sufficient to insert it into the ER membrane. The tail region of
VAPB however localises in a similar manner to the full-length protein.
The VAPB tail was then substituted into VAPA in place of the native tail. This construct
localised in a similar fashion to VAPB. Again this could be due to the exogenous VAPB
tail interacting with the endogenous VAPB protein.
Also interesting is the fact that the VAPB MSP domain pellets mostly into the P2 layer
and partially detergent extracts into Triton XI14, whereas the VAPA MSP construct is
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mostly cytoplasmic and does not detergent extract. The VAPA MSP construct behaves
as expected, as it has not been found to dimerise (Kaiser et al., 2005) so will not bind to
endogenous VAPA. The VAPB MSP domain may act in a different fashion and dimerise
or may be interacting with another ER protein, leading to its unexpected extraction. This
may also effect the localisation of VAPC, now identified in humans and mice, as it
contains almost the entire VAPB MSP domain.
Therefore, the minor differences in VAPA and VAPB homology in each domain appear
to lead to differences in localisation and possibly in protein interactions (Table 5.1).
These differences may reveal important differences in their roles in the ER.
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6. The VAP family and motor neuron degeneration
6.1 Background
VAPB has recently been identified as being linked to ALS via a mutation of a proline
residue at position 56 of the protein to a serine (Nishimura et al., 2004). This mutation
leads to three different phenotypes of the disease. One phenotype is atypical ALS8
where the patients have late-onset motor neuron death; fasiculations and disease
progression is 10-20 years. Some patients have late onset spinal muscular atrophy with
slowly progressing late on-set degeneration of cells in the anterior horn. The final set of
patients display, typical ALS and have a life expectancy of 2-3 years. The reason for this
wide range of phenotypes is not yet clear. However, there are so-called modifying factors
for ALS, which are not directly linked to the disease but may modify its progress. These
factors include ciliary neurotrophic factor (CNTF), a survival factor in spinal motor
neurons, which is decreased in the frontal cortex of ALS patients (Ono et al, 1999).
CNTF knockout mice also have slowly progressing motor neuron disease (Masu et al.,
1993). Apurinergic apyrimidic endonuclease (APEX), a DNA repair factor, is also
decreased in the frontal cortex of ALS patients (Kisby et al., 1997). It may play a role in
the Guamanian ALS-dementia-Parkinsonism complex as a metabolite of cycasin,
methylazoxymethanol (MAM), decreases APEX levels and activity in neurons (Esclaire
et al., 1999). Neurofilament aggregation in motor neurons is seen in both familial and
sporadic ALS (Cote et al., 1993). Recently 2 peripherin, a neuronal intermediate
filament, variants were found only in patients with ALS. One of these caused a
premature stop codon in the protein and disrupted neurofilament light chain assembly
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into the intermediate filament assembly. These peripherin variants may play a role in
some ALS cases (Gros-Louis et al., 2004).
There is also evidence that excess lipid accumulation can cause apoptosis and motor
neuron cell death. In some ALS patients, and in Cu/Zn SOD mutant mice, increased
oxidative stress in conjunction with accumulation of sphingomyelin, ceramides and
cholesterol esters. The inhibition of this lipid accumulation by pharmacological means
protects motor neurons from apoptotic cell death induced by oxidative stress (Cutler et
al., 2002). Exogenous ceramide can also cause apoptotic cell death. The mechanism by
which this occurs is unknown. However, there is evidence that ceramide can reduce the
phosphorylation of BAD, allowing it to heterodimerise with Bcl-2 and act as a pro-
apoptotic agent (Zundel et al., 1998). The liver X receptors (LXRa and LXR|3) are
ligand activated nuclear receptors that play a role in the regulation of cholesterol and
sterol trafficking between tissues. Their endogenous ligands are oxysterols (Andersson et
al., 2005). LXRa knockout animals accumulate cholesterol in their livers, which is
where the proteins get their name (Peet et al., 1998). However, the LXR[3 receptor is
broadly expressed in the developing and adult rodent brain (Kainu et al., 1996). In adult
mammals 95% of the cholesterol in the brain is synthesised in situ but synthesis exceeds
the brain's requirement so the cholesterol must be excreted. The major pathway for this
excretion is via cholesterol 24 hydroxylase. In the spinal cord there is 5-fold more
cholesterol synthesised than in the cerebellum or cerebrum but the concentration of
cholesterol is only 2-fold higher (Quan et al., 2003). The spinal cord must have a high
capacity for cholesterol secretion, but cholesterol 24 hydroxylase is not highly expressed
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there (Lund et al., 1999) so there must be some other means of excretion. The absence of
LXR(3 in male mice causes a selective vulnerability of large motor neurons. At 7 months
these mice exhibit impaired performance on the rota-rod and this impairment is
associated with lipid accumulation and loss of motor neurons in the spinal cord, together
with axonal atrophy and astrogliosis. The onset of this impairment is between 3 and 7
months, as 3 month-old mice do not appear to be impaired (Andersson et al., 2005). The
motor neuron selective cell death and late onset appear to be very similar to the effects
seen in ALS. Lipid accumulation in the spinal cord may be an important factor in human
cases of ALS.
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6.2 VAPB and VAPBP56S have different subcellular distributions
Recently our colleagues in Brazil (Nishimura et al., 2004) discovered that a mutation in
the VAPB gene was linked to an atypical form of ALS. This mutation leads to the
proline residue at position 56 of the protein being replaced with a serine residue (P56S).
Computational analysis of the change in residues predicts that the proline to serine
mutation will change the tertiary structure of the protein such that a kink in the structure
will become straight (Figure 6.1). This is predicted to alter the MSP-MSP protein
interactions of VAPB as proline 56 is a conserved residue thought to be key in these
interactions (Baker et al., 2002). This is not a key residue for FFAT protein binding so
these interactions should be unaffected (Loewen et al., 2005).
We made VAPB with the proline to serine mutation (VAPBP56S) fused to GFP and
expressed the protein in HEK293 cells and in primary hippocampal neurons. The
distribution of VAPBP56S in both HEK cells and neurons is altered with the mutant
version forming protein aggregates (Figure 6.2)
6.3 VAPA and VAPB without the MSP domain fused to GFP form
cisternae in the ER membrane but VAPB without the MSP
domain fused to HA does not
Low affinity interactions of ER membrane proteins is known to induce ER cisternae, or
stacked smooth ER biogenesis, when these proteins are fused to GFP (Snapp et al., 2003).
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Figure 6.1 The P56S mutation is predicted to affect the tertiary structure of the MSP
domain. The figure shows two MSP domains side by side and the arrows represent
(3 sheets. In a comparison between the wild-type and mutant VAPB MSP domains
computational analysis of the change in residues predicts that the proline to serine
mutation will change the tertiary structure of the protein such that a kink in the structure
will become straight.
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VAPB VAPB/DS.Red
Figure 6.2 VAPB and VAPB P56S have different subcellular distributions. HEK293
cells were transfected with VAPB/VAPBP56S and E19 primary cultured hippocampal
neurons were co-transfected with VAPB/VAPBP56S and DS.Red. VAPB has a diffuse,
perinuclear distribution whereas VAPBP56S has a punctate distribution, which suggests
that it forms protein aggregates (n=6).
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Figure 6.3 VAPA and VAPB without the MSP domain fused to GFP form cisternae in
the ER membrane but VAPB without the MSP domain fused to HA does not. A.
HEK293 cells expressing VAPA without the MSP domain fused to GFP and DS.Red-ER.
B. HEK293 cells expressing VAPB without the MSP domain fused to GFP and DS-Red-
ER. C. HEK293 cells expressing VAPB without the MSP domain fused to HA and HA
antibody stained. D. HEK293 cells expressing VAPBP56S fused to HA and HA
antibody stained (n=3).
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This also happens with the most highly overexpressing cells transfected with VAPA-GFP
or VAPB-GFP. However the more predominant, lower overexpressing cells do not give
cisternae but smooth reticular fluorescence. However, VAPA and VAPB without the
MSP domain fused to GFP overexpressing cells predominantly give cisternae (Figure
6.3A and B). This does not occur when these proteins are expressed with a non-
dimerising HA tag (Figure 6.3C). These cisternae are, therefore artificially induced by
the GFP fusion tag. However VAPBP56S fused to HA still has the characteristic protein
aggregates so these are not cisternae nor are they GFP induced.
6.4 VAPBP56S aggregates are associated with the ER
membrane but are not enriched in the Golgi apparatus
The gross cellular localisation of VAPB has previously been determined and it has been
found to associate with the ER and Golgi apparatus (Soussan et al., 1999). To find out
whether VAPBP56S shared this localisation it was co-transfected into HEK293 cells with
either DS.Red-ER or Cyan-Golgi. VAPBP56S aggregates partially co-localise with the
DS.Red-ER marker (Figure 6.4), so are associated with the ER membrane. However,
VAPBP56S aggregates do not colocalise with the Cyan-Golgi marker, therefore they are
not enriched in the Golgi apparatus (Figure 6.5).
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6.5 VAPAP56S forms similar aggregates to VAPBP56S and
shares the same intracellular distribution
To determine whether the P56S mutation in VAPA would have similar effects to the
VAPB mutant we made the P56S form of VAPA fused to GFP. This construct was
expressed in HEK293 cells along with either the DS.Red-ER or Cyan-Golgi markers.
VAPAP56S was found to form protein aggregates and to colocalise with DS.Red-ER
(Figure 6.6). Both VAPA and VAPB respond in a similar manner to the P56S mutation
on a gross level.
6.6 MSPP56S forms similar protein aggregates to MSP
To reveal whether the P56S mutation would have any effect upon the MSP aggregates
seen when the MSP domain is expressed alone the P56S version of VAPA MSP was
made. VAPA MSP-GFP and VAPA MSPP56S-GFP were expressed in HEK293 cells.
On a gross level both of these constructs form large protein aggregates within the cell
(Figure 6.7).
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Figure 6.4 VAPB and VAPBP56S and the ER. VAPB/VAPBP56S and DS.Red-ER were
co-transfected into E19 primary cultured hippocampal neurons and HEK293 cells. In
both cell types VAPB co-localised with the DS.Red-ER marker, as did the VAPBP56S
aggregates suggesting that the mutated protein is still found on the ER.
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VAPB Merge DS.Red-ER
VAPBP56S Merge DS.Red-ER
Hippocampal neurons
VAPB Merge DS.Red-ER
VAPB mutant Merge DS.Red-ER
VAPB Merge Cyan-Golgi
VAPBP56S Merge Cyan-Golgi
Figure 6.5 VAPB and VAPBP56S and cyan Golgi in HEK293 cells. VAPB/VAPBP56S
were co-transfected into HEK293 cells with a cyan-golgi marker. VAPB expression does
overlap with that of the cyan-golgi marker, therefore it is expressed in the Golgi.
However, VAPBP56S aggregates do not appear to overlap in expression with the cyan-
golgi marker (n=6).
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Figure 6.6 VAPA and VAPAP56S and ER or Golgi markers in HEK293 cells. VAPA
and VAPAP56S was co-transfected into HEK293 cells along with DS.Red-ER/Cyan-
golgi. VAPA and VAPAP56S colocalise with the DS.Red-ER marker. VAPA also
partially colocalises with the cyan-golgi marker but the VAPA aggregates do not appear
to co-localise with the Cyan-golgi marker (n=6).
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155
VAPA MSP domain VAPAP56S MSP domain
Figure 6.7 The VAPA MSP domain and VAPAP56S MSP domain were expressed
HEK293 cells. Both form large intracellular protein aggregates (n=6).
6.7 Triton X114 extraction of VAPBP56S demonstrates
differences in subcellular distribution to VAPB
To examine the subcellular localisation of VAPBP56S compared to that of VAPB the
VAPB-GFP and VAPBP56S-GFP constructs were expressed in HEK293 cells and PI,
P2, and S2 layers prepared as described in the materials and methods. The P2 layer was
detergent extracted (Bordier et al., 1981) with Triton XI14 and the samples were
analysed by western blots probed with GFP antibody. VAPB is found at higher levels in
the S2 layer and is not in the detergent phase (Figure 6.8). However VAPBP56S pellets
in the P2 layer and is completely in the detergent phase in TX114 (Figure 6.9). This
suggests that VAPBP56S acts more like VAPA than VAPB, and that the subcellular
localisation of VAPB is in some way dependent on the MSP domain or level of
multimersation of the protein.
6.8 P56S constructs without tails show that aggregation is not
dependent on membrane integration
To determine whether the aggregation of the P56S constructs was due to membrane
association VAPAP56S and VAPBP56S without their tail domains were constructed and
fused to GFP. These constructs were expressed in HEK293 cells and imaged. While
VAPA and VAPB without their tail domains show a cytoplasmic distribution the P56S
constructs form large protein aggregates (Figure 6.10 and 6.11).
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Figure 6.8 Triton XI14 partitioning of HEK293 cells, expressing VAPB-GFP. A.
VAPB-GFP was transiently transfected into HEK cells along with DS.Red-ER and the
cells were imaged after 48 hours. The VAPB-GFP partially co-localises with the
DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2 layers were prepared.
The P2 layer of the HEK cells was detergent partitioned using Triton XI14. VAPB-GFP
is found at a greater level in the S2 layer than the P2 layer and is mostly in the detergent
phase in Triton XI14 (n=3).
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Figure 6.9 Triton XI14 partitioning of HEK293 cells, expressing VAPBP56S-GFP. A.
VAPBP56S-GFP was transiently transfected into F1EK cells along with DS.Red-ER and
the cells were imaged after 48 hours. The VAPBP56S-GFP partially co-localises with
the DS.Red-ER marker. B. HEK cells were lysed and PI, P2, and S2 layers were
prepared. The P2 layer of the HEK cells was detergent extracted using Triton XI14.
VAPBP56S-GFP is found at a greater level in the P2 layer than in the S2 layer and is
mostly in the detergent phase in Triton XI14 (n=3).
159
VAPA VAPA-H
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Figure 6.10 VAPA, VAPAP56S, VAPA without Tail and VAPAP56S without Tail were
transfected into HEK293 cells. This revealed that the aggregates seen in the VAPAP56S
mutant did not depend upon the tail region of the protein (n=3).
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Figure 6.11 VAPB, VAPBP56S, VAPB without Tail and VAPBP56S without Tail were
transfected into HEK293 cells. This revealed that the aggregates seen in the VAPBP56S
mutant did not depend upon the tail region of the protein (n=3).
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This proves that integration into the membrane is not required for aggregation as a Triton
XI14 extraction of VAPBP56S without the tail shows that it is in the aqueous layer
(Figure 6.12).
6.9 Cross-linking experiments show that VAPBP56S forms
higher order structures than VAPB
Cross-linking studies reveal the size of multimers formed by a specific protein. VAPB
and VAPBP56S were expressed in HEK293 cells, left for 24 hours, treated with
disuccinimidyl suberate (DSS) for 10 minutes, the protein was extracted, run on an SDS
gel, transferred to a membrane and probed with VAPB antibody. VAPB is
predominantly found in lower order bands on the gel with a small amount in higher order
bands, whereas, VAPBP56S appears to be pushed towards forming larger order bands
with most of the protein expressed in these bands (Figure 6.13). The P56S mutation
appears to increase the likelihood of VAPB forming higher order structures, which the
wild-type protein can form, but rarely does.
6.10 VAPBP56S aggregates do not appear to include VAPA or
VAPB
To determine whether the VAPBP56S multimers included wild type VAPA or VAPB
VAPBP56S fused to GFP was expressed in HEK293 cells, they were left for 48 hours
and then subjected to paraformaldehyde fixation. The slides were then treated with
VAPA antibody. The VAPA antibody staining did not colocalise with the VAPBP56S
aggregates.
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Figure 6.12 Triton XI14 extraction of HEK293 cells, expressing VAPBP56S without
Tail-GFP. A. VAPBP56S without Tail-GFP was transiently transfected into HEK cells
along with DS.Red-ER and the cells were imaged after 48 hours. The VAPBP56S
without Tail-GFP partially co-localises with the DS.Red-ER marker. B. HEK cells were
lysed and PI, P2, and S2 layers were prepared. The P2 layer of the HEK cells was
detergent extracted using Triton XI14. VAPBP56S without Tail-GFP is found in the S2
layer (n=3).
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Figure 6.13 (Contributed by Paul Skehel) Cross-linking of VAPB-GFP and VAPBP56S-
GFP. Protein extracts were made from HEK293 cells transiently expressing VAPB or
VAPBP56S and these samples were cross-linked with increasing concentrations of
disuccinimidyl suberate (DSS). VAPBP56S forms higher order multimers than VAPB.
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VAPB-DS.Red and VAPBP56S-GFP or VAPB-GFP were expressed HEK293 cells and
then imaged. The VAPB-GFP colocalised completely with VAPB-DS.Red but the
VAPBP56S-GFP aggregates did not colocalise with the VAPB (Figure 6.14). Therefore
VAPBP56S aggregates do not appear to include wild type VAPA or VAPB.
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VAPB-GFP Merge DS.Red-VAPB
VAPBP56S-GFP Merge DS.Red-VAPB
VAPBP56S-GFP Merge VAPA antibody
Figure 6.14 VAPBP56S aggregates do not appear to contain wild-type VAPA or VAPB.
VAPB-GFP or VAPBP56S-GFP were co-transfected with DS.Red-VAPB into HEK293
cells. Although both of the wild-type VAPB constructs fully co-localised the aggregates
of VAPBP56S did not contain any wild-type VAPB when they were co-expressed.
VAPBP56S was also transfected into HEK cells, which were fixed and stained with
VAPA antibody. Again the VAPBP56S aggregates did not appear to contain wild-type
VAPA (n=6).
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6.11 Discussion
The locus 20ql3 was recently linked with ALS (Nishimura et al., 2004a) and hereditary
and autonomic neuronopathy 1 (Marques et ah, 2004). Our colleagues then identified the
protein involved, VAPB, which has a proline to serine mutation at position 56 in the
affected individuals (Nishimura et ah, 2004b).
We introduced this mutation into the VAPB protein and expressed it with a GFP tag in
primary cultured hippocampal neurons and HEK293 cells. VAPBP56S forms integral
ER membrane aggregates with a different subcellular localisation to endogenous VAPB.
These aggregates do not depend upon membrane integration, and crosslinking
experiments show that VAPBP56S forms higher order multimers more frequently than
endogenous VAPB. Also, these aggregates do not appear to contain wild type VAPA or
VAPB. The differences in subcellular localisation of VAPBP56S may therefore be due
to a blocked protein interaction rather than increased interactions with wild type VAPA.
Proline 56 is not involved in VAPB's interactions with FFAT proteins (Kaiser et ah,
2005), however, the changes in tertiary structure induced by this mutation may change
the position of crucial residues and therefore the binding site. This may lead to deficits in
oxysterol or ceramide binding or synthesis, which could have detrimental effects on
motor neurons. As it is the MSP domain that is affected, and this domain can affect
components of the ER stress response, it may be that this mutation decreases motor
neurons ability to sense ER stress. Previously, there have been reports that motor
neurons have reduced ability to sense ER stress and to induce production of heat shock
proteins (Batulan et ah, 2003). The additional factor of the P56S mutation in VAPB may
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decrease the motor neurons ability to sense ER stress to a critical level, thus inducing
apoptosis.
The discovery that P56S mutation may cause differences in subcellular localisation of the
VAPB, in ER stress responsiveness, and possibly, in protein interactions may, shed some
light on the molecular mechanisms involved in ALS.
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7. General Discussion
This study has concentrated upon the MSP domain of the VAP family of proteins. This
domain appears to have an important function in the VAP proteins as, when it is
expressed independently from the rest of the protein, large protein aggregates are formed.
Both primary hippocampal cultured neurons and HEK293 cells expressing this construct
undergo apoptotic cell death. In many neurodegenerative diseases, such as Alzheimer's,
Parkinson's or Huntintons disease, protein aggregates are found in the brains of patients.
There is much debate as to whether these protein aggregates are detrimental or beneficial.
Some investigators have shown that aggregation or inclusion body formation in
Huntington disease reduces neuronal cell death. It has been discovered that the more
diffuse forms of the protein Huntingtin are the ones more likely to cause apoptosis
(Arrasate et al., 2004). In the stably induced MSP domain cell line large protein
aggregates formed within 24 hours but were not present before this time point. However,
phosphoPERK induction was evident at 2 hours after induction when there was MSP
protein present but no large aggregates had formed. This suggests that the MSP domain
was producing toxic effects upon the cell before the large protein aggregates had formed.
ALS patients also have protein aggregates in the spinal cords of patients and our
colleagues in Brazil (Nishimura et al., 2004) identified a proline to serine mutation at
position 56 of the VAPB protein. When the VAPBP56S protein was expressed in primary
hippocampal neurons or HEK293 cells, it was discovered to have an ER localisation like
the endogenous VAPB. However, instead of a diffuse reticular pattern of fluorescence,
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the P56S mutation gives an aggregated pattern of distribution on the ER membrane. This
aggregation is not due to the proteins membrane localisation, as when the tail region is
removed the VAPBP56S protein still precociously aggregates. Cross-linking also shows
that the P56S mutation causes VAPB to preferentially form higher molecular weight
multimers. While endogenous VAPB can form these multimers, the P56S mutation
seems to increase the likelihood of aggregation. Perhaps surprisingly the VAPBP56S
aggregates do not sequester endogenous VAPA or VAPB.
Computational analysis of the change in residues predicts that the proline to serine
mutation will change the tertiary structure of the protein such that a kink in the structure
will become straight (Nishimura et al., 2004b). This may affect the VAPB protein's
ability to fold correctly. This has been investigated in the SOD1 mutants linked to ALS
where a correlation in protein stability and survival time for the patient carrying the
mutations was observed. Thus far, the mutations studied, which are linked to ALS, have
been identified as being gain of function mutations. Neither the SOD1 (Reaume et al.,
1996) nor the Alsin (Cai et al., 2005) knockout mice have shown an ALS phenotype. It is
thought, therefore, that these proteins have a toxic gain of function, possibly via
inappropriate protein interactions.
In a yeast two hybrid protein interaction screen the MSP domain of VAPA was found to
interact with OSBP and ORP9, proteins involved in lipid synthesis, as previously
determined in other studies (Wyles et al., 2004). Also found in the screen was a member
of the conserved oligomeric Golgi complex (COG7), which has been implicated in Golgi
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and COPI transport (Oka et al., 2004). These proteins all share a FFAT domain, which is
predicted to interact with lysine-46, threonine-48, lysine-86 and lysine-119 of VAPA
(Loewen et al., 2005).
Although proline 56 is not involved in VAPB's interactions with FFAT proteins (Kaiser
et al., 2005) the P56S mutation may decrease the VAPB protein's ability to interact with
other proteins, thus leading to motor neuron vulnerability with the onset of age. It is
known that in some ALS patients, and in Cu/Zn SOD mutant mice, increased oxidative
stress was discovered in conjunction with accumulation of sphingomyelin, ceramides and
cholesterol esters (Cutler et al., 2002). LXR(3 receptor knockout male mice also show
selective vulnerability of large motor neurons (Andersson et al., 2005). Therefore, it may
be that the interaction of VAPB with the oxysterol binding proteins and CERT is
disrupted in some way, leading to motor neuron death.
Autosomal recessive ALS has been linked to mutations in the Alsin gene. When the
truncated form of Alsin was expressed in monkey Cos-7 cells it resulted in enlargement
and accumulation of early endosomes, impairment of mitochondria trafficking and
fragmentation of the Golgi apparatus. As such, it is postulated that the Alsin protein is
involved in trafficking in neurons (Hadano et al., 2001). Rat VAPB antibodies were
found to inhibit retrograde intra Golgi transport and to result in the accumulation of COPI
vesicles (Soussan et al., 1999). COG7 is also involved in COPI transport (Oka et al.,
2004). Therefore, it is plausible that the mutation in VAPB also disrupts retrograde Golgi
trafficking in motor neurons.
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ATF6 was also identified as a possible binding partner for the MSP domain of VAP
proteins in the yeast two-hybrid screen. The yeast protein Scs2p, a homologue of
mammalian VAPA, has previously been identified as being involved in the yeast ER
stress response and in inositol auxotrophy (Kagiwada et al., 1998, Loewen et al., 2004)
via interactions with Opilp, an inositol transcription factor (Loewen et al., 2003). ATF6
is a bZIP protein, which is expressed as a type II membrane protein in the ER and is
activated by proteolysis in the mammalian ER stress response. When the MSP domain of
VAPA is expressed alone as a GFP fusion protein in HEK293 cells or primary
hippocampal cultured neurons, it forms large protein aggregates and these cells undergo
apoptotic cell death. When the apoptotic process was investigated in more detail it was
discovered that there was an increase in BiP mRNA in these cells as compared to
controls, there was an increase in PERK phosphorylation and caspase 3 production was
increased. These responses are all indicators of an increase in the ER stress response in
these cells, as compared with controls, and that this response triggers apoptotic cell death.
Full length VAPA also gave an increase in BiP mRNA production and it is postulated
that the mammalian VAP proteins are also involved in the ER stress response and that
this may be via the MSP domain interacting with ATF6.
Previously, there have been reports that motor neurons have reduced ability to sense ER
stress and to induce production of heat shock proteins (Batulan et al., 2003). The SOD1
mutations linked to ALS have been studied the most extensively and motor neuron death
has been linked to the ER stress response in SOD1 mutant mice (Tobisawa et al., 2003,
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Wootz et al., 2004). VAP proteins may perform a chaperoning function for specific
proteins so that they do not inappropriately interact. Therefore, the P56S mutation in the
VAPB protein may disrupt its ability to sense ER stress or its chaperoning ability, thus
leading to motor neuron cell death.
During our investigation of the differences between VAPA and VAPB we discovered
that, while VAPA behaves as an integral ER membrane protein and is in the detergent
phase of Triton XI14. VAPB is in lighter membrane fractions and is in the aqueous
phase of Triton XI14. This difference in ER membrane localization and interaction
appears to be in part mediated by the different tails of the proteins. However, when
VAPBP56S protein was studied it was found to behave as an integral ER membrane
protein and partially detergent extracts in Triton XI14 in a similar manner to VAPA. It
may be a joint interaction between the tail and MSP domains that is responsible for
VAPB's unusual localization. This difference in VAPBP56S localization may contribute
to motor neuron degeneration.
There are a range of clinical phenotypes associated with VAPBP56S induced ALS.
These include atypical ALS8 where the patients have late-onset motor neuron death;
fasiculations and disease progression is 10-20 years. Some patients have late onset spinal
muscular atrophy with slowly progressing late on-set degeneration of cells in the anterior
horn. The final set of patients display, typical ALS and have a life expectancy of 2-3
years. The reason for this wide range of phenotypes is not yet clear. However a number
of modifying factors for ALS disease progression have been found. These include
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CNTF, which is a spinal motor neuron survival factor (Ono et al, 1999), APEX, a DNA
repair factor (Kisby et al., 1997), and 2 peripherin, an intermediate filament in neurons
(Gros-Louis et al., 2004).
The GFP induced cisternae formation seen with the VAP proteins may be physiologically
relevant as they are similar to those seen in early onset torsion dystonia (Hewett et al.,
2000) and at the axonal-myelin sheath interface in spinal motor neurons (Li et al., 2005).
VAPA is also induced to form these cisternae when ORP-9 is overexpressed (Wyles et
al., 2004). These structures may be linked to new membrane formation as seen with the
yeast VAP homologue, SCS2, and the INOl pathway in yeast (Loewen et al., 2004).
However, some investigators postulate that these structures are purely artifactual (Snapp
et al., 2003).
The discovery that the splice variant of VAPB, VAPC, may exist in mice as well as in
humans may be significant. VAPC has no hydrophobic membrane-spanning domain,
therefore, it is unlikely to share the ER localisation ofVAPA and VAPB. It does contain
proline 56 and an MSP domain and may form toxic protein aggregates. Further study of
this member of the VAP family is essential to elucidating the role of these proteins in
ALS.
This study has used a variety of approaches to determine VAP protein function. The
yeast-two hybrid assay with the MSP domain of VAPA has revealed many potentially
positive interactions, which remain to be validated by co-immunoprecipitation or pull-
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down assay. Studies to determine whether the VAPB MSP domain shares the same
protein interactions, which is highly likely as the MSP domain is highly conserved, and
whether the P56S mutation affects the protein interactions would also be illuminating.
The increase in phospho-PERK induction and caspase 3 activation due to the expression
of the VAPA MSP domain, is interesting as this may mean that the VAP proteins may be
effectors of the ER stress response under physiological or pathological conditions.
However, further studies will have to be carried out to determine whether this effect is
purely artifactual and whether it has any relevance in the pathology of ALS8. The
discovery that ALS8 is linked to the P56S mutation in VAPB has led to a new avenue of
research into the function of the VAP proteins. Our studies have concentrated on the
localization of the VAPB and VAPBP56S proteins thus far. Future research will
probably focus on the generation of mice expressing the VAPBP56S protein and this
should yield many interesting results.
In summary it has been discovered that the MSP domain of the VAP proteins is involved
in many potentially interesting interactions including those linked to lipid synthesis,
COPI transport and the ER stress response. This domain when expressed alone gives
large protein aggregates and initiates increased BiP mRNA production, PERK
phosphorylation and caspase 3 production. This leads us to postulate that the VAP
proteins are involved in the mammalian ER stress response possibly via interactions of
their MSP domains with ATF6. The P56S mutation of VAPB linked to ALS causes
aggregation and mislocalisation of the protein. This may lead to decreased ability to
interact with other proteins and motor neuron vulnerability.
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